IL-12	B-protein
induces	O
IFN	B-protein
regulating	I-protein
factor-1	I-protein
(	I-protein
IRF-1	I-protein
)	I-protein
gene	O
expression	O
in	O
human	O
NK	B-cell_type
and	O
T	B-cell_type
cells	I-cell_type
.	O

IL-12	B-protein
is	O
a	O
critical	B-protein
immunoregulatory	I-protein
cytokine	I-protein
that	O
promotes	O
cell-mediated	O
immune	O
responses	O
and	O
the	O
differentiation	O
of	O
naive	O
CD4+	B-cell_type
cells	I-cell_type
to	O
Th1	B-cell_type
cells	I-cell_type
;	O
however	O
,	O
relatively	O
few	O
IL-12	B-protein
target	O
genes	O
have	O
been	O
identified	O
.	O

To	O
better	O
clarify	O
the	O
molecular	O
basis	O
of	O
IL-12	B-protein
action	O
,	O
we	O
set	O
out	O
to	O
characterize	O
genes	O
up-regulated	O
by	O
IL-12	B-protein
,	O
first	O
by	O
contrasting	O
IL-12	B-DNA
-and	O
IFN-alpha-inducible	B-DNA
genes	I-DNA
.	O

We	O
identified	O
several	O
genes	O
up-regulated	O
by	O
IL-12	B-protein
,	O
namely	O
,	O
MIP-1alpha	B-protein
,	O
MIP-1beta	B-protein
,	O
IL-1RA	B-protein
,	O
and	O
IFN	B-protein
regulatory	I-protein
factor-1	I-protein
(	I-protein
IRF-1	I-protein
)	I-protein
.	O

IRF-1	B-protein
is	O
a	O
transcription	B-protein
factor	I-protein
regulated	O
by	O
IFNs	B-protein
that	O
is	O
also	O
essential	O
for	O
Th1	B-cell_type
responses	O
.	O

We	O
demonstrated	O
that	O
IL-12	B-protein
directly	O
up-regulates	O
IRF-1	B-protein
to	O
the	O
same	O
extent	O
as	O
IFN-alpha	B-protein
in	O
normal	O
human	O
T	B-cell_type
cells	I-cell_type
and	O
in	O
NK	B-cell_type
cells	I-cell_type
.	O

We	O
showed	O
that	O
IL-12	B-protein
had	O
a	O
direct	O
effect	O
on	O
IRF-1	B-protein
,	O
an	O
effect	O
not	O
mediated	O
indirectly	O
by	O
the	O
induction	O
of	O
IFN-gamma	B-protein
production	O
.	O

Furthermore	O
,	O
IL-2	B-protein
and	O
IL-12	B-protein
synergistically	O
induced	O
IRF-1	B-protein
,	O
whereas	O
IFN-alpha	B-protein
and	O
IL-12	B-protein
did	O
not	O
.	O

The	O
participation	O
of	O
STAT4	B-protein
in	O
the	O
regulation	O
of	O
IRF-1	B-protein
was	O
demonstrated	O
in	O
two	O
ways	O
.	O

First	O
,	O
STAT4	B-protein
was	O
required	O
for	O
the	O
IL-12	B-protein
-dependent	O
transactivation	O
of	O
an	O
IRF-1	B-DNA
reporter	I-DNA
construct	I-DNA
,	O
and	O
second	O
,	O
STAT4	B-protein
binding	O
to	O
the	O
IRF-1	B-DNA
promoter	I-DNA
was	O
shown	O
using	O
EMSA	O
.	O

In	O
contrast	O
to	O
IL-12	B-protein
,	O
no	O
up-regulation	O
of	O
IRF-1	B-protein
was	O
found	O
in	O
IL-4-stimulated	B-cell_line
cells	I-cell_line
,	O
and	O
IL-4	B-protein
did	O
not	O
block	O
IL-12	B-protein
-dependent	O
up-regulation	O
of	O
IRF-1	B-protein
.	O

Therefore	O
,	O
IRF-1	B-protein
may	O
be	O
an	O
important	O
contributor	O
to	O
IL-12	B-protein
signaling	O
,	O
and	O
we	O
speculate	O
that	O
the	O
defective	O
IL-12	B-protein
responses	O
seen	O
in	O
IRF	B-protein
-1-/-	O
mice	O
might	O
be	O
attributable	O
,	O
in	O
part	O
,	O
to	O
the	O
absence	O
of	O
this	O
transcription	B-protein
factor	I-protein
.	O

X	NULL
Boldly	NULL
GolnVivo	NULL
``	NULL
``	NULL
BioLegend®	NULL
#	NULL
m	NULL
meJournal	NULL
of	NULL
IL-12	NULL
Induces	NULL
IFN	NULL
Regulating	NULL
Factor-1	NULL
-	NULL
.	NULL

--	NULL
=	NULL
``	NULL
``	NULL
'Immun010	NULL
gy	NULL
(	NULL
IRF-1	NULL
)	NULL
Gene	NULL
Expression	NULL
in	NULL
Human	NULL
NK	NULL
and	NULL
T	NULL
Cells	NULL
This	NULL
inf	NULL
tion	NULL
i	NULL
t	NULL
Jérome	NULL
Galon	NULL
,	NULL
Chitra	NULL
Sudarshan	NULL
,	NULL
Satochi	NULL
Ito	NULL
,	NULL
David	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

-__-	NULL
___	NULL
__	NULL
Finbloom	NULL
and	NULL
John	NULL
J.	NULL
O'Shea	NULL
J	NULL
Immunol	NULL
1999	NULL
;	NULL
162	NULL
;	NULL
:7256-7262	NULL
;	NULL
;	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/162/12/7256	NULL
References	NULL
_	NULL
This	NULL
article	NULL
cites	NULL
38	NULL
articles	NULL
,	NULL
20	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/162/12/7256.full	NULL
#	NULL
ref-list-	NULL
1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_-	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
IL-12	NULL
Induces	NULL
IFN	NULL
Regulating	NULL
Factor-1	NULL
(	NULL
IRF-1	NULL
)	NULL
Gene	NULL
Expression	NULL
in	NULL
Human	NULL
NK	NULL
and	NULL
T	NULL
Cells	NULL
Jérome	NULL
Galon	NULL
,	NULL
'*	NULL
Chitra	NULL
Sudarshan	NULL
,	NULL
*	NULL
Satochi	NULL
Ito	NULL
,	NULL
``	NULL
David	NULL
Finbloom	NULL
,	NULL
``	NULL
and	NULL
John	NULL
J.	NULL
O'Shea*	NULL
IL-12	NULL
is	NULL
a	NULL
critical	NULL
immunoregulatory	NULL
cytokine	NULL
that	NULL
promotes	NULL
cell-mediated	NULL
immune	NULL
responses	NULL
and	NULL
the	NULL
differentiation	NULL
of	NULL
naive	NULL
CD4*	NULL
cells	NULL
to	NULL
Th1	NULL
cells	NULL
;	NULL
however	NULL
,	NULL
relatively	NULL
few	NULL
IL-12	NULL
target	NULL
genes	NULL
have	NULL
been	NULL
identified	NULL
.	NULL

To	NULL
better	NULL
clarify	NULL
the	NULL
molecular	NULL
basis	NULL
of	NULL
IL-12	NULL
action	NULL
,	NULL
we	NULL
set	NULL
out	NULL
to	NULL
characterize	NULL
genes	NULL
up-regulated	NULL
by	NULL
IL-12	NULL
,	NULL
first	NULL
by	NULL
contrasting	NULL
IL-12-	NULL
and	NULL
IFN-a-inducible	NULL
genes	NULL
.	NULL

We	NULL
identified	NULL
several	NULL
genes	NULL
up-regulated	NULL
by	NULL
IL-12	NULL
,	NULL
namely	NULL
,	NULL
MIP-1	NULL
@	NULL
,	NULL
MIP-1f3	NULL
,	NULL
IL-1	NULL
RA	NULL
,	NULL
and	NULL
IFN	NULL
regulatory	NULL
factor-1	NULL
(	NULL
IRF-1	NULL
)	NULL
.	NULL

IRF-1	NULL
is	NULL
a	NULL
transcription	NULL
factor	NULL
regulated	NULL
by	NULL
IFNs	NULL
that	NULL
is	NULL
also	NULL
essential	NULL
for	NULL
Th1	NULL
responses	NULL
.	NULL

We	NULL
demonstrated	NULL
that	NULL
IL-12	NULL
directly	NULL
up-regulates	NULL
IRF-1	NULL
to	NULL
the	NULL
same	NULL
extent	NULL
as	NULL
IFN-a	NULL
«	NULL
in	NULL
normal	NULL
human	NULL
T	NULL
cells	NULL
and	NULL
in	NULL
NK	NULL
cells	NULL
.	NULL

We	NULL
showed	NULL
that	NULL
IL-12	NULL
had	NULL
a	NULL
direct	NULL
effect	NULL
on	NULL
IRF-1	NULL
,	NULL
an	NULL
effect	NULL
not	NULL
mediated	NULL
indirectly	NULL
by	NULL
the	NULL
induction	NULL
of	NULL
IFN-y	NULL
production	NULL
.	NULL

Furthermore	NULL
,	NULL
IL-2	NULL
and	NULL
IL-12	NULL
synergistically	NULL
induced	NULL
IRF-1	NULL
,	NULL
whereas	NULL
IFN-a	NULL
and	NULL
IL-12	NULL
did	NULL
not	NULL
.	NULL

The	NULL
participation	NULL
of	NULL
STAT4	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
IRF-1	NULL
was	NULL
demonstrated	NULL
in	NULL
two	NULL
ways	NULL
.	NULL

First	NULL
,	NULL
STAT4	NULL
was	NULL
required	NULL
for	NULL
the	NULL
IL-12-dependent	NULL
transactivation	NULL
of	NULL
an	NULL
IRF-1	NULL
reporter	NULL
construct	NULL
,	NULL
and	NULL
second	NULL
,	NULL
STAT4	NULL
binding	NULL
to	NULL
the	NULL
IRF-1	NULL
promoter	NULL
was	NULL
shown	NULL
using	NULL
EMSA	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
IL-12	NULL
,	NULL
no	NULL
up-regulation	NULL
of	NULL
IRF-1	NULL
was	NULL
found	NULL
in	NULL
IL-4-stimulated	NULL
cells	NULL
,	NULL
and	NULL
IL-4	NULL
did	NULL
not	NULL
block	NULL
IL-12-dependent	NULL
up-regulation	NULL
of	NULL
IRF-1	NULL
.	NULL

Therefore	NULL
,	NULL
IRF-1	NULL
may	NULL
be	NULL
an	NULL
important	NULL
contributor	NULL
to	NULL
IL-12	NULL
signaling	NULL
,	NULL
and	NULL
we	NULL
speculate	NULL
that	NULL
the	NULL
defective	NULL
IL-12	NULL
responses	NULL
seen	NULL
in	NULL
IRF-1~'~	NULL
mice	NULL
might	NULL
be	NULL
attributable	NULL
,	NULL
in	NULL
part	NULL
,	NULL
to	NULL
the	NULL
absence	NULL
of	NULL
this	NULL
transcription	NULL
factor	NULL
.	NULL

The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
1999	NULL
,	NULL
162	NULL
:	NULL
7256-7262.	NULL
cell-mediated	NULL
immune	NULL
responses	NULL
and	NULL
drives	NULL
the	NULL
differentia-	NULL
tion	NULL
of	NULL
naive	NULL
CD4	NULL
*	NULL
cells	NULL
to	NULL
Th1	NULL
cells	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Its	NULL
importance	NULL
is	NULL
exemplified	NULL
by	NULL
IL-12	NULL
knockout	NULL
mice	NULL
,	NULL
which	NULL
are	NULL
deficient	NULL
in	NULL
their	NULL
ability	NULL
to	NULL
generate	NULL
a	NULL
normal	NULL
Th1	NULL
response	NULL
and	NULL
to	NULL
produce	NULL
IFN-y	NULL
(	NULL
2	NULL
)	NULL
.	NULL

IL-12	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK2	NULL
and	NULL
TYK2	NULL
(	NULL
3	NULL
)	NULL
,	NULL
which	NULL
,	NULL
in	NULL
turn	NULL
,	NULL
phosphorylate	NULL
other	NULL
substrates	NULL
,	NULL
including	NULL
the	NULL
transcription	NULL
factors	NULL
STAT4	NULL
,	NULL
STAT1	NULL
(	NULL
4	NULL
)	NULL
,	NULL
and	NULL
STAT3	NULL
(	NULL
5	NULL
,	NULL
6	NULL
)	NULL
;	NULL
STAT4	NULL
'~	NULL
mice	NULL
,	NULL
like	NULL
IL-12	NULL
``	NULL
~	NULL
mice	NULL
,	NULL
have	NULL
defective	NULL
Th1	NULL
differentiation	NULL
and	NULL
impaired	NULL
cell-mediated	NULL
immunity	NULL
.	NULL

Despite	NULL
the	NULL
importance	NULL
of	NULL
IL-12	NULL
,	NULL
there	NULL
is	NULL
relatively	NULL
little	NULL
information	NULL
pertaining	NULL
to	NULL
IL-12-inducible	NULL
genes	NULL
and	NULL
genes	NULL
known	NULL
to	NULL
be	NULL
regulated	NULL
by	NULL
STAT4	NULL
(	NULL
7	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
IL-12	NULL
,	NULL
however	NULL
,	NULL
many	NULL
IFN-inducible	NULL
genes	NULL
have	NULL
been	NULL
characterized	NULL
(	NULL
8	NULL
,	NULL
9	NULL
)	NULL
.	NULL

While	NULL
it	NULL
is	NULL
clear	NULL
that	NULL
STAT1	NULL
is	NULL
essential	NULL
for	NULL
many	NULL
IFN-a	NULL
responses	NULL
,	NULL
IFN-	NULL
«	NULL
,	NULL
like	NULL
IL-12	NULL
,	NULL
activates	NULL
STAT4	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
both	NULL
IFN-	NULL
and	NULL
IL-12	NULL
activate	NULL
TYK2	NULL
(	NULL
10	NULL
,	NULL
11	NULL
)	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
IFN-	NULL
«	NULL
and	NULL
IL-12	NULL
may	NULL
share	NULL
a	NULL
subset	NULL
of	NULL
target	NULL
genes	NULL
.	NULL

The	NULL
similarity	NULL
in	NULL
IFN-	NULL
and	NULL
IL-12	NULL
signaling	NULL
prompted	NULL
us	NULL
to	NULL
define	NULL
commonalities	NULL
and	NULL
differences	NULL
in	NULL
genes	NULL
regulated	NULL
by	NULL
IFN-and	NULL
IL-12	NULL
.	NULL

One	NULL
well-characterized	NULL
IFN-inducible	NULL
gene	NULL
is	NULL
IFN	NULL
regulatory	NULL
factor-1	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
IRF-1	NULL
knockout	NULL
mice	NULL
have	NULL
a	NULL
broad	NULL
range	NULL
of	NULL
defects	NULL
.	NULL

For	NULL
instance	NULL
,	NULL
IRF-l-deficient	NULL
mice	NULL
have	NULL
impaired	NULL
ability	NULL
to	NULL
undergo	NULL
DNA	NULL
damage-induced	NULL
cell	NULL
cycle	NULL
arrest	NULL
I	NULL
nterleukin-12	NULL
is	NULL
a	NULL
critical	NULL
immunoregulatory	NULL
cytokine	NULL
for	NULL
*Lymphocyte	NULL
Cell	NULL
Biology	NULL
Section	NULL
,	NULL
Arthritis	NULL
and	NULL
Rheumatism	NULL
Branch	NULL
,	NULL
National	NULL
Institute	NULL
of	NULL
Arthritis	NULL
and	NULL
Musculoskeletal	NULL
Diseases	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
and	NULL
*Division	NULL
of	NULL
Cytokine	NULL
Biology	NULL
,	NULL
Center	NULL
for	NULL
Biologics	NULL
Evaluation	NULL
and	NULL
Research	NULL
,	NULL
Food	NULL
and	NULL
Drug	NULL
Administration	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
20892	NULL
Received	NULL
for	NULL
publication	NULL
August	NULL
14	NULL
,	NULL
1998	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
March	NULL
29	NULL
,	NULL
1999	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
adverfisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL
'	NULL

Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Jérome	NULL
Galon	NULL
,	NULL
ARB/NIAMS	NULL
,	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
Building	NULL
10	NULL
,	NULL
Room	NULL
9N	NULL
252	NULL
,	NULL
10	NULL
Center	NULL
Drive	NULL
,	NULL
MSC-1820	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
20892-1820	NULL
.	NULL

E-mail	NULL
address	NULL
:	NULL
galonj	NULL
@	NULL
exchange.nih.gov	NULL
?	NULL

Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
IRF-1	NULL
,	NULL
IFN	NULL
regulatory	NULL
factor-1	NULL
;	NULL
MIP	NULL
,	NULL
macrophage-inflammatory	NULL
protein	NULL
;	NULL
SBE	NULL
,	NULL
STAT	NULL
binding	NULL
element	NULL
;	NULL
CHX	NULL
,	NULL
cycloheximide	NULL
.	NULL

Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
(	NULL
13	NULL
,	NULL
14	NULL
)	NULL
.	NULL

These	NULL
mice	NULL
also	NULL
have	NULL
defects	NULL
in	NULL
inflammatory	NULL
and	NULL
innate	NULL
immune	NULL
responses	NULL
(	NULL
15	NULL
)	NULL
and	NULL
disruption	NULL
of	NULL
NK	NULL
and	NULL
T	NULL
cell	NULL
development	NULL
(	NULL
16	NULL
,	NULL
17	NULL
)	NULL
.	NULL

Importantly	NULL
,	NULL
IRF-1	NULL
knockout	NULL
mice	NULL
demonstrate	NULL
the	NULL
involvement	NULL
of	NULL
IRF-1	NULL
in	NULL
multiple	NULL
stages	NULL
of	NULL
the	NULL
Th1	NULL
differentiation	NULL
(	NULL
18	NULL
,	NULL
19	NULL
)	NULL
.	NULL

IRF-1~'~	NULL
mice	NULL
have	NULL
defective	NULL
IL-12	NULL
and	NULL
IFN-y	NULL
production	NULL
and	NULL
exaggerated	NULL
IL-4	NULL
secretion	NULL
.	NULL

The	NULL
lack	NULL
of	NULL
NK	NULL
cells	NULL
in	NULL
IRF-1~'~	NULL
mice	NULL
contributes	NULL
,	NULL
in	NULL
part	NULL
,	NULL
to	NULL
the	NULL
impairment	NULL
in	NULL
IFN-y	NULL
production	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
there	NULL
is	NULL
defective	NULL
IL-12	NULL
production	NULL
,	NULL
which	NULL
has	NULL
been	NULL
attributed	NULL
to	NULL
the	NULL
presence	NULL
of	NULL
a	NULL
potential	NULL
IRF-l-responsive	NULL
element	NULL
in	NULL
the	NULL
IL-12p40	NULL
gene	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Most	NULL
importantly	NULL
,	NULL
however	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
impaired	NULL
IL-12	NULL
production	NULL
,	NULL
CD4	NULL
*	NULL
T	NULL
cells	NULL
from	NULL
IRF-1~'~	NULL
mice	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
have	NULL
impaired	NULL
responsiveness	NULL
to	NULL
IL-12	NULL
,	NULL
as	NULL
measured	NULL
by	NULL
IFN-y	NULL
production	NULL
after	NULL
IL-12	NULL
stimulation	NULL
(	NULL
18	NULL
,	NULL
19	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
although	NULL
IRF-1	NULL
was	NULL
initially	NULL
described	NULL
as	NULL
an	NULL
IFN-inducible	NULL
transcription	NULL
factor	NULL
,	NULL
the	NULL
phenotype	NULL
of	NULL
IRF-1-deficient	NULL
mice	NULL
is	NULL
dramatically	NULL
different	NULL
from	NULL
that	NULL
of	NULL
IFN-y	NULL
or	NULL
IFN-	NULL
receptor-de-ficient	NULL
mice	NULL
,	NULL
which	NULL
argues	NULL
that	NULL
IRE-1	NULL
serves	NULL
functions	NULL
other	NULL
than	NULL
simply	NULL
transmitting	NULL
IFN-mediated	NULL
signals	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

21	NULL
)	NULL
.	NULL

This	NULL
was	NULL
the	NULL
second	NULL
issue	NULL
that	NULL
led	NULL
us	NULL
to	NULL
investigate	NULL
the	NULL
potential	NULL
regulation	NULL
of	NULL
IRF-1	NULL
by	NULL
IL-12	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
report	NULL
that	NULL
IFN-a	NULL
«	NULL
and	NULL
IL-12	NULL
up-regulate	NULL
a	NULL
number	NULL
of	NULL
genes	NULL
in	NULL
common	NULL
,	NULL
including	NULL
macrophage-inflammatory	NULL
protein	NULL
(	NULL
MIP	NULL
)	NULL
-1a	NULL
@	NULL
«	NULL
,	NULL
MIP-1	NULL
$	NULL
3	NULL
,	NULL
and	NULL
IL-1RA	NULL
.	NULL

Importantly	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
IFN-a	NULL
,	NULL
IL-12	NULL
and	NULL
IL-2	NULL
,	NULL
but	NULL
not	NULL
IL-4	NULL
,	NULL
directly	NULL
up-regulate	NULL
IRF-1	NULL
expression	NULL
.	NULL

Thus	NULL
,	NULL
although	NULL
IRF-1	NULL
was	NULL
initially	NULL
characterized	NULL
as	NULL
an	NULL
IFN-inducible	NULL
gene	NULL
,	NULL
IRF-1	NULL
can	NULL
be	NULL
viewed	NULL
as	NULL
a	NULL
transcription	NULL
factor	NULL
that	NULL
is	NULL
also	NULL
regulated	NULL
by	NULL
cytokines	NULL
that	NULL
participate	NULL
in	NULL
Th1	NULL
responses	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Materials	NULL
rhIL-12	NULL
and	NULL
a	NULL
human	NULL
IFN-y	NULL
immunoassay	NULL
kit	NULL
were	NULL
purchased	NULL
from	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
(	NULL
Minneapolis	NULL
,	NULL
MN	NULL
)	NULL
.	NULL

Human	NULL
IL-2	NULL
was	NULL
provided	NULL
by	NULL
Dr.	NULL
C.	NULL
Reynolds	NULL
(	NULL
National	NULL
Cancer	NULL
Institute	NULL
,	NULL
Frederick	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

Polyclonal	NULL
rabbit	NULL
anti-STAT4	NULL
Ab	NULL
was	NULL
purchased	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
(	NULL
Santa	NULL
Cruz	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Rabbit	NULL
polyclonal	NULL
anti-STAT1	NULL
Ab	NULL
was	NULL
provided	NULL
by	NULL
Dr.	NULL
A.	NULL
Larner	NULL
0022-1767/99/	NULL
$	NULL
02.00	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
(	NULL
Cleveland	NULL
Clinic	NULL
Foundation	NULL
,	NULL
Cleveland	NULL
,	NULL
OH	NULL
)	NULL
.	NULL

An	NULL
RNA	NULL
extraction	NULL
kit	NULL
(	NULL
RNAgents	NULL
Total	NULL
RNA	NULL
Isolation	NULL
System	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
Promega	NULL
(	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
,	NULL
and	NULL
RiboQuant	NULL
Multiprobe	NULL
RNase	NULL
Protection	NULL
System	NULL
was	NULL
purchased	NULL
from	NULL
PharMingen	NULL
(	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Cell	NULL
culture	NULL
supernatants	NULL
of	NULL
cell	NULL
were	NULL
collected	NULL
at	NULL
4	NULL
h	NULL
,	NULL
and	NULL
IFN-y	NULL
levels	NULL
were	NULL
analyzed	NULL
using	NULL
a	NULL
commercial	NULL
ELISA	NULL
kit	NULL
(	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
)	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
in-structions	NULL
.	NULL

The	NULL
plasmid	NULL
p3xGAS-luc	NULL
,	NULL
containing	NULL
the	NULL
STAT	NULL
binding	NULL
site	NULL
of	NULL
the	NULL
IRF-1	NULL
gene	NULL
(	NULL
22	NULL
)	NULL
,	NULL
was	NULL
provided	NULL
by	NULL
Dr.	NULL
R.	NULL
Pine	NULL
(	NULL
The	NULL
Public	NULL
Health	NULL
Research	NULL
Institute	NULL
,	NULL
New	NULL
York	NULL
,	NULL
NY	NULL
)	NULL
,	NULL
and	NULL
peDNA3-STAT4	NULL
was	NULL
provided	NULL
by	NULL
Dr.	NULL
J.	NULL
Ihle	NULL
(	NULL
St.	NULL
Jude	NULL
Children	NULL
's	NULL
Hospital	NULL
,	NULL
Memphis	NULL
,	NULL
TN	NULL
)	NULL
.	NULL

Plasmids	NULL
containing	NULL
the	NULL
cDNA	NULL
for	NULL
IL-12RfB1	NULL
and	NULL
IL-12Rf2	NULL
in	NULL
expression	NULL
vector	NULL
pEF-BOS	NULL
were	NULL
provided	NULL
by	NULL
Dr.	NULL
U.	NULL
Gubler	NULL
(	NULL
Hoffmann-La	NULL
Roche	NULL
,	NULL
Nutley	NULL
,	NULL
NJ	NULL
)	NULL
.	NULL

LipofectAMINE	NULL
was	NULL
purchased	NULL
from	NULL
Life	NULL
Technologies	NULL
(	NULL
Gaithersburg	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

Cells	NULL
NK3.3	NULL
cells	NULL
were	NULL
provided	NULL
by	NULL
Dr.	NULL
J.	NULL
Kornbluth	NULL
(	NULL
Arkansas	NULL
Cancer	NULL
Research	NULL
Center	NULL
,	NULL
Little	NULL
Rock	NULL
,	NULL
AR	NULL
)	NULL
.	NULL

PBMC	NULL
from	NULL
healthy	NULL
donors	NULL
were	NULL
isolated	NULL
by	NULL
Ficoll-Paque	NULL
(	NULL
Pharmacia	NULL
,	NULL
Piscataway	NULL
,	NULL
NJ	NULL
)	NULL
gradient	NULL
centrifugation	NULL
,	NULL
activated	NULL
with	NULL
PHA	NULL
(	NULL
2	NULL
ug/ml	NULL
)	NULL
for	NULL
72	NULL
h	NULL
,	NULL
and	NULL
cultured	NULL
for	NULL
an	NULL
additional	NULL
day	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
IL-2	NULL
(	NULL
40	NULL
IU/m	NULL
!	NULL
)	NULL

,	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
3	NULL
,	NULL
5	NULL
)	NULL
.	NULL

RNase	NULL
protection	NULL
assay	NULL
and	NULL
Northern	NULL
analysis	NULL
Total	NULL
RNA	NULL
was	NULL
extracted	NULL
from	NULL
cytokine-activated	NULL
cells	NULL
using	NULL
RNAgents	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

The	NULL
RNase	NULL
protection	NULL
assay	NULL
was	NULL
conducted	NULL
as	NULL
follows	NULL
:	NULL
°°P-labeled	NULL
RNA	NULL
probe	NULL
was	NULL
synthesized	NULL
using	NULL
SP6	NULL
RNA	NULL
polymerase	NULL
for	NULL
GAPDH	NULL
,	NULL
ISG15	NULL
,	NULL
ISG54	NULL
,	NULL
and	NULL
DNA	NULL
templates	NULL
or	NULL
with	NULL
T7	NULL
RNA	NULL
polymerase	NULL
for	NULL
granylate-binding	NULL
protein	NULL
(	NULL
GBP	NULL
)	NULL
,	NULL
IFN-y-inducible	NULL
protein-10	NULL
,	NULL
IRF-1	NULL
,	NULL
and	NULL
the	NULL
multiprobe	NULL
template	NULL
set	NULL
(	NULL
PharMingen	NULL
)	NULL
.	NULL

DNA	NULL
was	NULL
digested	NULL
with	NULL
DNase	NULL
I	NULL
(	NULL
Boehringer	NULL
Mannheim	NULL
,	NULL
Indianapolis	NULL
,	NULL
IN	NULL
)	NULL
,	NULL
and	NULL
RNA	NULL
probes	NULL
were	NULL
extracted	NULL
with	NULL
phenol	NULL
and	NULL
chloroform	NULL
and	NULL
precipitated	NULL
with	NULL
ethanol	NULL
.	NULL

Labeled	NULL
RNA	NULL
probes	NULL
were	NULL
hybridized	NULL
overnight	NULL
at	NULL
56°C	NULL
to	NULL
target	NULL
RNA	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
and	NULL
were	NULL
digested	NULL
with	NULL
Tl	NULL
RNase	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
.	NULL

The	NULL
protected	NULL
mRNA	NULL
fragment	NULL
was	NULL
extracted	NULL
with	NULL
phenol	NULL
and	NULL
chloroform	NULL
,	NULL
precipitated	NULL
with	NULL
ethanol	NULL
,	NULL
resolved	NULL
on	NULL
a	NULL
6	NULL
%	NULL
denaturating	NULL
polyacrylamide	NULL
gel	NULL
,	NULL
and	NULL
subjected	NULL
to	NULL
autoradiography	NULL
.	NULL

Gene	NULL
transcripts	NULL
were	NULL
identified	NULL
by	NULL
the	NULL
length	NULL
of	NULL
the	NULL
protected	NULL
fragments	NULL
.	NULL

Equal	NULL
loading	NULL
of	NULL
RNA	NULL
was	NULL
estimated	NULL
from	NULL
the	NULL
amounts	NULL
of	NULL
protected	NULL
fragments	NULL
of	NULL
two	NULL
housekeeping	NULL
genes	NULL
,	NULL
namely	NULL
,	NULL
L32	NULL
and	NULL
GAPDH	NULL
.	NULL

For	NULL
Northern	NULL
blots	NULL
,	NULL
RNA	NULL
samples	NULL
(	NULL
20	NULL
ug	NULL
)	NULL
were	NULL
electrophoresed	NULL
on	NULL
1	NULL
%	NULL
agarose	NULL
gels	NULL
containing	NULL
formaldehyde	NULL
(	NULL
Ambion	NULL
,	NULL
Austin	NULL
,	NULL
TX	NULL
)	NULL
,	NULL
transferred	NULL
to	NULL
BrightStar	NULL
Plus	NULL
membranes	NULL
(	NULL
Ambion	NULL
)	NULL
,	NULL
and	NULL
cross-linked	NULL
to	NULL
the	NULL
membrane	NULL
by	NULL
UV	NULL
light	NULL
(	NULL
UV	NULL
Stratalinker	NULL
,	NULL
Spectronics	NULL
,	NULL
Rochester	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

A	NULL
*°P-labeled	NULL
RNA	NULL
IRF-1	NULL
probe	NULL
was	NULL
synthesized	NULL
,	NULL
and	NULL
10°	NULL
cpm/ml	NULL
of	NULL
radiolabeled	NULL
probe	NULL
was	NULL
hybridized	NULL
to	NULL
membranes	NULL
for	NULL
16	NULL
h.	NULL
The	NULL
membranes	NULL
were	NULL
washed	NULL
at	NULL
62°C	NULL
and	NULL
exposed	NULL
to	NULL
film	NULL
.	NULL

Luciferase	NULL
assay	NULL
The	NULL
NIH	NULL
3T3	NULL
cells	NULL
stably	NULL
transfected	NULL
with	NULL
the	NULL
a	NULL
,	NULL
B	NULL
,	NULL
and	NULL
y	NULL
,	NULL
chains	NULL
of	NULL
the	NULL
IL-2R	NULL
and	NULL
JAK3	NULL
(	NULL
NIH	NULL
3T3fgyJAK3	NULL
)	NULL
(	NULL
23	NULL
)	NULL
and	NULL
NIH	NULL
3T3	NULL
cells	NULL
(	NULL
3	NULL
X	NULL
10°	NULL
cells	NULL
per	NULL
point	NULL
)	NULL
were	NULL
transfected	NULL
with	NULL
0.3	NULL
pg	NULL
of	NULL
3xGAS-luciferase	NULL
reporter	NULL
plasmid	NULL
,	NULL
the	NULL
IRF-1-promoter	NULL
luciferase	NULL
construct	NULL
,	NULL
pcDNA3-STAT4	NULL
,	NULL
pEF-BOS-IL-12Rf1	NULL
,	NULL
and	NULL
pEF-BOS-IL-12RB2	NULL
using	NULL
LipofectAMINE	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
.	NULL

The	NULL
luciferase	NULL
reporter	NULL
construct	NULL
alone	NULL
(	NULL
pGL2-B	NULL
)	NULL
and	NULL
that	NULL
containing	NULL
the	NULL
IRF-1	NULL
promoter	NULL
(	NULL
1.3-kb	NULL
5	NULL
'	NULL
flanking	NULL
region	NULL
of	NULL
the	NULL
human	NULL
IRF-1	NULL
gene	NULL
)	NULL
or	NULL
the	NULL
mutant	NULL
STAT	NULL
binding	NULL
element	NULL
(	NULL
SBE	NULL
)	NULL
site	NULL
at	NULL
position	NULL
-123	NULL
of	NULL
the	NULL
IRF-1	NULL
promoter	NULL
(	NULL
mutant	NULL
sequence	NULL
5'-GATTTCCCCtccAT-3	NULL
``	NULL
)	NULL
were	NULL
provided	NULL
by	NULL
Dr.	NULL
Thomas	NULL
A.	NULL
Hamilton	NULL
(	NULL
Cleveland	NULL
Clinic	NULL
Foundation	NULL
,	NULL
Cleveland	NULL
,	NULL
OH	NULL
)	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Transfected	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
cytokines	NULL
,	NULL
lysed	NULL
,	NULL
and	NULL
assayed	NULL
for	NULL
luciferase	NULL
activity	NULL
(	NULL
Promega	NULL
)	NULL
.	NULL

EMSA	NULL
Cell	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
cytokine-stimulated	NULL
NK3.3	NULL
cells	NULL
,	NULL
and	NULL
EMSAs	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
(	NULL
25	NULL
)	NULL
using	NULL
a	NULL
*°P-labeled	NULL
double-stranded	NULL
oligonucleotide	NULL
corresponding	NULL
to	NULL
the	NULL
human	NULL
IRF-1	NULL
promoter	NULL
(	NULL
5'-AGCTTCAGCCTGATTTCCCCGAAATGACGGA-3	NULL
'	NULL
)	NULL
and	NULL
a	NULL
control	NULL
oligonucleotide	NULL
(	NULL
5	NULL
-CTGCAGTAACGCCATTTTGCAAGGCATGAA-3	NULL
'	NULL
.	NULL

In	NULL
supershift	NULL
assays	NULL
,	NULL
complexes	NULL
were	NULL
incubated	NULL
with	NULL
1	NULL
pl	NULL
of	NULL
STAT1	NULL
Ab	NULL
,	NULL
STAT4	NULL
Ab	NULL
,	NULL
or	NULL
preimmune	NULL
rabbit	NULL
serum	NULL
at	NULL
4°C	NULL
for	NULL
30	NULL
min	NULL
.	NULL

The	NULL
complexes	NULL
were	NULL
electrophoresed	NULL
through	NULL
a	NULL
5	NULL
%	NULL
nondenaturing	NULL
acrylamide	NULL
gel	NULL
and	NULL
subjected	NULL
to	NULL
autoradiography	NULL
.	NULL

Results	NULL
Identification	NULL
of	NULL
IFN-a-	NULL
and	NULL
IL-12-induced	NULL
genes	NULL
Since	NULL
there	NULL
appear	NULL
to	NULL
be	NULL
some	NULL
similarities	NULL
in	NULL
IFN-	NULL
and	NULL
IL-12	NULL
signaling	NULL
,	NULL
we	NULL
surveyed	NULL
IFN-inducible	NULL
genes	NULL
to	NULL
determine	NULL
whether	NULL
7257	NULL
Fa	NULL
NZC	NULL
A	NULL
t	NULL
mira	NULL
-	NULL
KRA	NULL
WR®Q	NULL
pani	NULL
MIP-1a	NULL
*	NULL
CB	NULL
#	NULL
--	NULL
*	NULL
GBP	NULL
MP1	NULL
;	NULL
li	NULL
«	NULL
-	NULL
ISG15	NULL
rvpee	NULL
-	NULL
RQ	NULL
I1SG54	NULL
Granz	NULL
B	NULL
ZTC	NULL
GAPDH	NULL
12	NULL
3	NULL
1	NULL
2	NULL
3	NULL
8	NULL
a	NULL
Am	NULL
||	NULL
Cs	NULL
B	NULL
o	NULL
&	NULL
3	NULL
3	NULL
al	NULL
_	NULL
_	NULL
112	NULL
3	NULL
GAPDH	NULL
»	NULL
«	NULL
»	NULL
a	NULL
»	NULL
T	NULL
)	NULL
a	NULL
C	NULL
o	NULL
€	NULL
3	NULL
a	NULL
IRF-1	NULL
'	NULL
»	NULL
«	NULL
-	NULL
«	NULL
-*	NULL
123	NULL
4	NULL
GAPDH	NULL
.	NULL

«	NULL
»	NULL
@	NULL
w	NULL
«	NULL
»	NULL
»	NULL
»	NULL
wot	NULL
tis	NULL
as	NULL
m	NULL
FIGURE	NULL
1	NULL
.	NULL

IL-12	NULL
and	NULL
IFN-a	NULL
«	NULL
induce	NULL
a	NULL
common	NULL
set	NULL
of	NULL
genes	NULL
,	NULL
including	NULL
IRF-1	NULL
.	NULL

A	NULL
,	NULL
Identification	NULL
of	NULL
mRNA	NULL
species	NULL
differentially	NULL
expressed	NULL
in	NULL
primary	NULL
T	NULL
cells	NULL
activated	NULL
by	NULL
IL-12	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL
)	NULL

or	NULL
IFN-	NULL
«	NULL
(	NULL
1000	NULL
IU/ml	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
stimulated	NULL
for	NULL
4	NULL
h	NULL
,	NULL
RNA	NULL
was	NULL
extracted	NULL
,	NULL
and	NULL
the	NULL
RNase	NULL
protection	NULL
assay	NULL
was	NULL
conducted	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

B	NULL
and	NULL
C	NULL
,	NULL
IL-12	NULL
and	NULL
IL-2	NULL
induce	NULL
IRF-1	NULL
.	NULL

NK3.3	NULL
cells	NULL
(	NULL
B	NULL
)	NULL
and	NULL
activated	NULL
primary	NULL
T	NULL
cells	NULL
(	NULL
>	NULL
95	NULL
%	NULL
CD3	NULL
cells	NULL
)	NULL
(	NULL
C	NULL
)	NULL
were	NULL
stimulated	NULL
for	NULL
4	NULL
h	NULL
with	NULL
IFN-a	NULL
(	NULL
1000	NULL
IU/m	NULL
!	NULL
)	NULL

,	NULL
IL-12	NULL
(	NULL
10	NULL
ng/ml	NULL
!	NULL
)	NULL

,	NULL
or	NULL
IL-2	NULL
(	NULL
1000	NULL
IU/ml	NULL
)	NULL
.	NULL

RNA	NULL
was	NULL
extracted	NULL
,	NULL
and	NULL
the	NULL
RNase	NULL
protection	NULL
assay	NULL
was	NULL
conducted	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
using	NULL
radiolabeled	NULL
IRF-1	NULL
and	NULL
GAPDH	NULL
probes	NULL
.	NULL

any	NULL
of	NULL
these	NULL
were	NULL
IL-12	NULL
inducible	NULL
.	NULL

IFN-	NULL
@	NULL
-inducible	NULL
genes	NULL
are	NULL
relatively	NULL
well	NULL
characterized	NULL
and	NULL
include	NULL
GBP	NULL
,	NULL
ISG15	NULL
,	NULL
and	NULL
ISG54	NULL
,	NULL
as	NULL
well	NULL
as	NULL
MIP-1a	NULL
@	NULL
,	NULL
MIP-1	NULL
3	NULL
,	NULL
and	NULL
IL-1RA	NULL
(	NULL
26-28	NULL
)	NULL
;	NULL
we	NULL
confirmed	NULL
this	NULL
in	NULL
the	NULL
experiment	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1A	NULL
.	NULL

As	NULL
is	NULL
evident	NULL
in	NULL
this	NULL
experi-ment	NULL
,	NULL
IL-12	NULL
up-regulated	NULL
a	NULL
subset	NULL
of	NULL
these	NULL
genes	NULL
.	NULL

Specifically	NULL
,	NULL
as	NULL
with	NULL
IFN-a	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
IL-12	NULL
up-regulated	NULL
IL-1RA	NULL
,	NULL
MIP-1	NULL
@	NULL
,	NULL
and	NULL
MIP-1	NULL
3	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
IL-12	NULL
did	NULL
not	NULL
up-regulate	NULL
GBP	NULL
,	NULL
ISG15	NULL
,	NULL
and	NULL
ISG54	NULL
.	NULL

This	NULL
is	NULL
not	NULL
unexpected	NULL
,	NULL
as	NULL
the	NULL
latter	NULL
genes	NULL
contain	NULL
IFN-stimulation	NULL
response	NULL
element	NULL
in	NULL
their	NULL
promoters	NULL
,	NULL
which	NULL
bind	NULL
STATI/STAT2/p48	NULL
complexes	NULL
,	NULL
and	NULL
IL-12	NULL
has	NULL
not	NULL
been	NULL
shown	NULL
to	NULL
activate	NULL
STAT2	NULL
.	NULL

IL-12	NULL
has	NULL
previously	NULL
been	NULL
shown	NULL
to	NULL
up-regulate	NULL
granzyme	NULL
B	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
we	NULL
found	NULL
that	NULL
IFN-a	NULL
also	NULL
up-regulated	NULL
this	NULL
gene	NULL
.	NULL

Notably	NULL
,	NULL
we	NULL
found	NULL
that	NULL
another	NULL
gene	NULL
implicated	NULL
in	NULL
the	NULL
apoptotic	NULL
pathway	NULL
,	NULL
RVP1	NULL
,	NULL
was	NULL
up-regulated	NULL
by	NULL
both	NULL
IFN-a	NULL
and	NULL
IL-12	NULL
.	NULL

As	NULL
control	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
DAD	NULL
!	NULL

is	NULL
shown	NULL
;	NULL
neither	NULL
IFN-a	NULL
«	NULL
nor	NULL
IL-12	NULL
affected	NULL
expression	NULL
of	NULL
this	NULL
gene	NULL
or	NULL
GAPDH	NULL
.	NULL

IL-12	NULL
up-regulates	NULL
IRF-1	NULL
expression	NULL
Because	NULL
of	NULL
the	NULL
number	NULL
of	NULL
genes	NULL
we	NULL
found	NULL
that	NULL
were	NULL
commonly	NULL
regulated	NULL
by	NULL
IFN-	NULL
and	NULL
IL-12	NULL
,	NULL
we	NULL
next	NULL
analyzed	NULL
another	NULL
gene	NULL
typically	NULL
induced	NULL
by	NULL
IFNs	NULL
,	NULL
namely	NULL
IRF-1	NULL
,	NULL
a	NULL
well-characterized	NULL
transcription	NULL
factor	NULL
that	NULL
is	NULL
important	NULL
in	NULL
regulating	NULL
a	NULL
variety	NULL
of	NULL
genes	NULL
.	NULL

We	NULL
therefore	NULL
sought	NULL
to	NULL
determine	NULL
whether	NULL
IRF-1	NULL
was	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
7258	NULL
IL-12	NULL
CHX/L-12	NULL
8	NULL
Z	NULL
o	NULL
&	NULL
IRF-1	NULL
w	NULL
1	NULL
2	NULL
3	NULL
4	NULL
capo	NULL
®®	NULL
@	NULL
@	NULL
«	NULL
-	NULL
«	NULL
o	NULL
«	NULL
o	NULL
#	NULL
«	NULL
t	NULL
FIGURE	NULL
2	NULL
.	NULL

Effect	NULL
of	NULL
CHX	NULL
treatment	NULL
on	NULL
the	NULL
IL-12	NULL
induction	NULL
of	NULL
IRF-1	NULL
.	NULL

CHX	NULL
(	NULL
20	NULL
ug/ml	NULL
)	NULL
was	NULL
added	NULL
for	NULL
30	NULL
min	NULL
before	NULL
stimulation	NULL
of	NULL
NK3.3	NULL
cells	NULL
with	NULL
the	NULL
indicated	NULL
cytokines	NULL
.	NULL

RNA	NULL
was	NULL
prepared	NULL
from	NULL
each	NULL
of	NULL
these	NULL
,	NULL
and	NULL
the	NULL
RNase	NULL
protection	NULL
assay	NULL
was	NULL
conducted	NULL
,	NULL
using	NULL
radiolabeled	NULL
IRF-1	NULL
and	NULL
GAPDH	NULL
probes	NULL
.	NULL

uniquely	NULL
regulated	NULL
by	NULL
IFN-a	NULL
or	NULL
whether	NULL
IL-12	NULL
also	NULL
up-regulated	NULL
its	NULL
expression	NULL
.	NULL

Because	NULL
NK3.3	NULL
cells	NULL
are	NULL
a	NULL
useful	NULL
model	NULL
system	NULL
to	NULL
study	NULL
IL-12	NULL
signaling	NULL
,	NULL
we	NULL
first	NULL
tested	NULL
inducibility	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
IFN-	NULL
«	NULL
induced	NULL
expression	NULL
of	NULL
IRF-1	NULL
as	NULL
expected	NULL
.	NULL

Interestingly	NULL
,	NULL
IL-12	NULL
also	NULL
induced	NULL
IRF-1	NULL
mRNA	NULL
expression	NULL
to	NULL
the	NULL
same	NULL
extent	NULL
as	NULL
IFN-a	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lane	NULL
3	NULL
vs	NULL
lane	NULL
2	NULL
)	NULL
;	NULL
increased	NULL
IRF-1	NULL
mRNA	NULL
accumulation	NULL
in	NULL
IL-12-stimulated	NULL
NK3.3	NULL
cells	NULL
was	NULL
reproducibly	NULL
detected	NULL
in	NULL
10	NULL
different	NULL
experiments	NULL
.	NULL

Because	NULL
IL-12	NULL
and	NULL
IL-2	NULL
have	NULL
overlapping	NULL
effects	NULL
on	NULL
some	NULL
genes	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
IFN-y	NULL
;	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
we	NULL
next	NULL
sought	NULL
to	NULL
determine	NULL
whether	NULL
IL-2	NULL
had	NULL
similar	NULL
or	NULL
distinct	NULL
effects	NULL
relative	NULL
to	NULL
IL-12	NULL
and	NULL
IFN-a	NULL
@	NULL
.	NULL

We	NULL
found	NULL
that	NULL
IL-2	NULL
stimulation	NULL
also	NULL
induced	NULL
IRF-1	NULL
mRNA	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

To	NULL
confirm	NULL
that	NULL
IL-12	NULL
and	NULL
IL-2	NULL
up-regulated	NULL
IRF-1	NULL
in	NULL
normal	NULL
human	NULL
T	NULL
cells	NULL
,	NULL
we	NULL
stimulated	NULL
activated	NULL
T	NULL
cells	NULL
with	NULL
IFN-a	NULL
,	NULL
IL-12	NULL
,	NULL
and	NULL
IL-2	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

1C	NULL
,	NULL
stimulation	NULL
with	NULL
IFN-a	NULL
,	NULL
IL-12	NULL
,	NULL
and	NULL
IL-2	NULL
induced	NULL
IRF-1	NULL
mRNA	NULL
up-regulation	NULL
(	NULL
Zanes	NULL
2-4	NULL
)	NULL
;	NULL
increased	NULL
IRF-1	NULL
mRNA	NULL
accumulation	NULL
in	NULL
human	NULL
T	NULL
cells	NULL
was	NULL
reproducibly	NULL
detected	NULL
in	NULL
five	NULL
different	NULL
experiments	NULL
,	NULL
using	NULL
cells	NULL
from	NULL
five	NULL
different	NULL
donors	NULL
.	NULL

The	NULL
basal	NULL
level	NULL
of	NULL
IRF-1	NULL
was	NULL
higher	NULL
in	NULL
T	NULL
cells	NULL
than	NULL
in	NULL
NK3.3	NULL
cells	NULL
,	NULL
presumably	NULL
because	NULL
it	NULL
was	NULL
necessary	NULL
to	NULL
preactivate	NULL
T	NULL
cells	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
to	NULL
induce	NULL
IL-12R	NULL
and	NULL
IL-2R	NULL
«	NULL
-chain	NULL
expression	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
used	NULL
NK3.3	NULL
cells	NULL
in	NULL
subsequent	NULL
experiments	NULL
.	NULL

Since	NULL
IRF-1	NULL
is	NULL
regulated	NULL
by	NULL
IFNs	NULL
,	NULL
and	NULL
since	NULL
IL-12	NULL
and	NULL
IL-2	NULL
are	NULL
potent	NULL
inducers	NULL
of	NULL
IFN-y	NULL
,	NULL
we	NULL
next	NULL
considered	NULL
the	NULL
possibility	NULL
that	NULL
the	NULL
IL-12	NULL
and	NULL
IL-2	NULL
induction	NULL
of	NULL
IRF-1	NULL
was	NULL
indirectly	NULL
mediated	NULL
by	NULL
the	NULL
production	NULL
of	NULL
IFN-y	NULL
.	NULL

We	NULL
used	NULL
several	NULL
approaches	NULL
to	NULL
address	NULL
this	NULL
issue	NULL
.	NULL

First	NULL
,	NULL
we	NULL
directly	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
IFN-y	NULL
on	NULL
IRF-1	NULL
,	NULL
and	NULL
under	NULL
conditions	NULL
tested	NULL
,	NULL
stimulation	NULL
of	NULL
the	NULL
NK3.3	NULL
cells	NULL
with	NULL
IFN-y	NULL
did	NULL
not	NULL
induce	NULL
IRF-1	NULL
.	NULL

The	NULL
lack	NULL
of	NULL
effect	NULL
of	NULL
IFN-y	NULL
was	NULL
due	NULL
to	NULL
an	NULL
absence	NULL
of	NULL
the	NULL
IFN-y-R	NULL
B	NULL
chain	NULL
in	NULL
this	NULL
cell	NULL
line	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
RNase	NULL
protection	NULL
assay	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
attempted	NULL
to	NULL
inhibit	NULL
the	NULL
IRF-1	NULL
induction	NULL
with	NULL
Abs	NULL
against	NULL
IFN-y	NULL
.	NULL

Anti-IFN-y	NULL
antibodies	NULL
have	NULL
no	NULL
effect	NULL
on	NULL
IL-12-up-regulation	NULL
,	NULL
whereas	NULL
anti-IL-12	NULL
Abs	NULL
completely	NULL
inhibited	NULL
its	NULL
induction	NULL
of	NULL
IRF-1	NULL
.	NULL

Finally	NULL
,	NULL
we	NULL
also	NULL
measured	NULL
the	NULL
amount	NULL
of	NULL
IFN-y	NULL
in	NULL
the	NULL
culture	NULL
supernatants	NULL
after	NULL
4	NULL
h	NULL
of	NULL
stimulation	NULL
and	NULL
found	NULL
that	NULL
no	NULL
IFN-y	NULL
was	NULL
produced	NULL
at	NULL
this	NULL
time	NULL
point	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
confirm	NULL
that	NULL
the	NULL
enhancement	NULL
of	NULL
expression	NULL
of	NULL
IRF-1	NULL
by	NULL
IL-12	NULL
was	NULL
a	NULL
direct	NULL
effect	NULL
,	NULL
we	NULL
next	NULL
added	NULL
cycloheximide	NULL
(	NULL
CHX	NULL
)	NULL
,	NULL
a	NULL
potent	NULL
protein	NULL
synthesis	NULL
inhibitor	NULL
,	NULL
to	NULL
our	NULL
cultures	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2B	NULL
,	NULL
CHX	NULL
did	NULL
not	NULL
inhibit	NULL
the	NULL
IL-12	NULL
induction	NULL
of	NULL
IRF-1	NULL
mRNA	NULL
;	NULL
in	NULL
fact	NULL
,	NULL
CHX	NULL
augmented	NULL
the	NULL
induction	NULL
(	NULL
Zane	NULL
3	NULL
vs	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

This	NULL
was	NULL
not	NULL
due	NULL
to	NULL
CHX	NULL
alone	NULL
,	NULL
since	NULL
CHX	NULL
,	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
stimulation	NULL
,	NULL
did	NULL
not	NULL
alter	NULL
IRF-1	NULL
mRNA	NULL
levels	NULL
as	NULL
compared	NULL
with	NULL
the	NULL
control	NULL
INDUCTION	NULL
OF	NULL
IRF-1	NULL
BY	NULL
IL-12	NULL
AND	NULL
IL-2	NULL
,	NULL
BUT	NULL
NOT	NULL
BY	NULL
IL-4	NULL
N6	NULL
A	NULL
a	NULL
&	NULL
+	NULL
+	NULL
oq	NULL
2	NULL
V	NULL
§	NULL
o	NULL
1	NULL
2	NULL
&	NULL
=	NULL
3	NULL
IRF-1	NULL
«	NULL
se	NULL
ISG15	NULL
GAPDH	NULL
«	NULL
«	NULL
»	NULL
a	NULL
»	NULL
«	NULL
»	NULL
an	NULL
an	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
B	NULL
IRF-1	NULL
-	NULL
cae	NULL
ISG15	NULL
GAPDH	NULL
%	NULL
*	NULL
«	NULL
»	NULL
a	NULL
»	NULL
am	NULL
am	NULL
an	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
C	NULL
IRF-1	NULL
«	NULL
¥	NULL
C	NULL
#	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
FIGURE	NULL
3	NULL
.	NULL

IL-12	NULL
and	NULL
IL-2	NULL
synergistically	NULL
induce	NULL
IRF-1	NULL
expression	NULL
.	NULL

A	NULL
,	NULL
NK3.3	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
4	NULL
h	NULL
with	NULL
IL-2	NULL
(	NULL
1000	NULL
IU/ml	NULL
)	NULL
,	NULL
IL-12	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
,	NULL
IFN-a	NULL
(	NULL
1000	NULL
IU/m	NULL
!	NULL
)	NULL

,	NULL
and	NULL
IL-2	NULL
or	NULL
IFN-a	NULL
in	NULL
combination	NULL
with	NULL
IL-12	NULL
.	NULL

B	NULL
,	NULL
Cells	NULL
were	NULL
pretreated	NULL
with	NULL
CHX	NULL
before	NULL
stimulation	NULL
,	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

2B	NULL
.	NULL

RNA	NULL
was	NULL
prepared	NULL
,	NULL
and	NULL
the	NULL
RNase	NULL
protection	NULL
assay	NULL
was	NULL
conducted	NULL
using	NULL
radiolabeled	NULL
IRF-1	NULL
,	NULL
ISG15	NULL
,	NULL
and	NULL
GAPDH	NULL
probes	NULL
.	NULL

C	NULL
,	NULL
Northern	NULL
blot	NULL
analysis	NULL
of	NULL
IRF-1	NULL
mRNA	NULL
in	NULL
NK3.3	NULL
cells	NULL
after	NULL
pretreatment	NULL
with	NULL
CHX	NULL
and	NULL
stimulation	NULL
with	NULL
cytokines	NULL
for	NULL
4	NULL
h.	NULL
RNA	NULL
was	NULL
isolated	NULL
,	NULL
and	NULL
samples	NULL
(	NULL
20	NULL
ug	NULL
)	NULL
were	NULL
run	NULL
on	NULL
a	NULL
1	NULL
%	NULL
agarose	NULL
gel	NULL
,	NULL
transferred	NULL
to	NULL
nylon	NULL
membranes	NULL
,	NULL
and	NULL
hybridized	NULL
with	NULL
an	NULL
IRE-1	NULL
probe	NULL
.	NULL

(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
up-regulation	NULL
was	NULL
reproducibly	NULL
detected	NULL
in	NULL
six	NULL
different	NULL
experiments	NULL
and	NULL
suggests	NULL
the	NULL
existence	NULL
of	NULL
a	NULL
labile	NULL
inhibitor	NULL
.	NULL

We	NULL
next	NULL
examined	NULL
the	NULL
effect	NULL
of	NULL
stimulation	NULL
with	NULL
a	NULL
combination	NULL
of	NULL
IL-12	NULL
with	NULL
IL-2	NULL
or	NULL
IFN-a	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
IL-12	NULL
,	NULL
IL-2	NULL
,	NULL
and	NULL
IFN-a	NULL
induced	NULL
IRF-1	NULL
mRNA	NULL
(	NULL
Zanes	NULL
2-4	NULL
)	NULL
.	NULL

The	NULL
combination	NULL
of	NULL
IFN-a	NULL
@	NULL
and	NULL
IL-12	NULL
induced	NULL
IRF-1	NULL
mRNA	NULL
to	NULL
the	NULL
same	NULL
extent	NULL
as	NULL
IL-12	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
whereas	NULL
IL-12	NULL
and	NULL
IL-2	NULL
had	NULL
a	NULL
synergistic	NULL
effect	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
the	NULL
induction	NULL
of	NULL
ISG15	NULL
was	NULL
also	NULL
assessed	NULL
;	NULL
IL-2	NULL
and	NULL
IL-12	NULL
either	NULL
separately	NULL
or	NULL
in	NULL
combination	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
this	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

34	NULL
,	NULL
lanes	NULL
2	NULL
,	NULL
3	NULL
,	NULL
and	NULL
5	NULL
)	NULL
.	NULL

To	NULL
confirm	NULL
that	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
combination	NULL
of	NULL
IL-2	NULL
and	NULL
IL-12	NULL
was	NULL
direct	NULL
and	NULL
not	NULL
mediated	NULL
by	NULL
the	NULL
induction	NULL
of	NULL
another	NULL
cytokine	NULL
,	NULL
the	NULL
experiment	NULL
was	NULL
repeated	NULL
using	NULL
pretreatment	NULL
with	NULL
CHX	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
IL-12	NULL
,	NULL
IL-2	NULL
,	NULL
and	NULL
IFN-	NULL
«	NULL
induced	NULL
IRF-1	NULL
expression	NULL
(	NULL
Zanes	NULL
2-4	NULL
)	NULL
.	NULL

When	NULL
tested	NULL
together	NULL
,	NULL
IL-12	NULL
and	NULL
IL-2	NULL
again	NULL
had	NULL
a	NULL
synergistic	NULL
effect	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CHX	NULL
,	NULL
whereas	NULL
IL-12	NULL
and	NULL
IFN-a	NULL
did	NULL
not	NULL
(	NULL
Zane	NULL
6	NULL
)	NULL
.	NULL

These	NULL
results	NULL
determined	NULL
by	NULL
RNase	NULL
protection	NULL
assay	NULL
were	NULL
also	NULL
confirmed	NULL
by	NULL
Northern	NULL
analysis	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

Densitometry	NULL
showed	NULL
an	NULL
18-fold	NULL
induction	NULL
of	NULL
IRF-1	NULL
with	NULL
IL-12	NULL
,	NULL
a	NULL
15-fold	NULL
induction	NULL
with	NULL
IL-2	NULL
,	NULL
and	NULL
a	NULL
43-fold	NULL
induction	NULL
with	NULL
the	NULL
combination	NULL
of	NULL
both	NULL
cytokines	NULL
.	NULL

We	NULL
next	NULL
compared	NULL
the	NULL
kinetics	NULL
of	NULL
IRF-1	NULL
induction	NULL
after	NULL
IL-12	NULL
or	NULL
IFN-a	NULL
treatment	NULL
,	NULL
quantitating	NULL
the	NULL
fold	NULL
induction	NULL
of	NULL
IRF-1	NULL
by	NULL
den-sitometry	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
CHX	NULL
alone	NULL
had	NULL
no	NULL
effect	NULL
as	NULL
compared	NULL
with	NULL
the	NULL
untreated	NULL
cells	NULL
(	NULL
Ct	NULL
lanes	NULL
)	NULL
.	NULL

Both	NULL
with	NULL
or	NULL
without	NULL
CHX	NULL
,	NULL
IL-12	NULL
had	NULL
little	NULL
effect	NULL
on	NULL
IRF-1	NULL
expression	NULL
after	NULL
30	NULL
min	NULL
or	NULL
1	NULL
h	NULL
,	NULL
but	NULL
the	NULL
effect	NULL
was	NULL
more	NULL
pronounced	NULL
after	NULL
4	NULL
h	NULL
(	NULL
14-	NULL
and	NULL
33-fold	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
wet	NULL
~-	NULL
@	NULL
t	NULL
wae	NULL
«	NULL
--	NULL
04	NULL
!	NULL

o	NULL
05	NULL
1	NULL
4	NULL
0.5	NULL
1	NULL
4	NULL
0.5	NULL
1	NULL
4hr	NULL
£22009	NULL
_UL___I	NULL
IL-12	NULL
-	NULL
CHXILA12	NULL
IFN	NULL
«	NULL
fold	NULL
induction	NULL
8	NULL
0	NULL
0.50	NULL
1	NULL
4	NULL
0.50	NULL
1	NULL
4	NULL
0.50	NULL
1	NULL
4	NULL
0.50	NULL
1	NULL
4	NULL
hr	NULL
L	NULL
I	NULL
L	NULL
I	NULL
1	NULL
I	NULL
L	NULL
1	NULL
Ct	NULL
IL-12	NULL
CHX	NULL
IFN	NULL
a	NULL
IL-12	NULL
FIGURE	NULL
4	NULL
.	NULL

IL-12	NULL
and	NULL
IFN-	NULL
induce	NULL
IRF-1	NULL
with	NULL
different	NULL
kinetics	NULL
.	NULL

Shown	NULL
is	NULL
an	NULL
RNase	NULL
protection	NULL
assay	NULL
analysis	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
IRF-1	NULL
and	NULL
GAPDH	NULL
following	NULL
IL-12	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
and	NULL
IFN-	NULL
(	NULL
1000	NULL
IU/ml	NULL
!	NULL
)	NULL

stimu-lation	NULL
.	NULL

Stimulated	NULL
NK3.3	NULL
cells	NULL
were	NULL
collected	NULL
at	NULL
times	NULL
indicated	NULL
,	NULL
RNA	NULL
was	NULL
isolated	NULL
,	NULL
and	NULL
the	NULL
RNase	NULL
protection	NULL
assay	NULL
was	NULL
conducted	NULL
.	NULL

Fold	NULL
induction	NULL
as	NULL
compared	NULL
with	NULL
untreated	NULL
and	NULL
unstimulated	NULL
cells	NULL
were	NULL
calculated	NULL
and	NULL
normalized	NULL
to	NULL
GAPDH	NULL
levels	NULL
.	NULL

induction	NULL
,	NULL
respectively	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
IRF-1	NULL
induction	NULL
by	NULL
IFN-a	NULL
is	NULL
maximal	NULL
after	NULL
1-h	NULL
stimulation	NULL
(	NULL
23-fold	NULL
induction	NULL
)	NULL
and	NULL
declined	NULL
by	NULL
4	NULL
h.	NULL
Since	NULL
both	NULL
IL-12	NULL
and	NULL
IFN-a	NULL
exert	NULL
their	NULL
effect	NULL
by	NULL
similar	NULL
mech-anisms	NULL
,	NULL
there	NULL
is	NULL
no	NULL
obvious	NULL
explanation	NULL
for	NULL
this	NULL
difference	NULL
.	NULL

One	NULL
possible	NULL
explanation	NULL
would	NULL
be	NULL
that	NULL
IL-12	NULL
activates	NULL
IRF-1	NULL
through	NULL
STAT4	NULL
,	NULL
whereas	NULL
the	NULL
major	NULL
STAT	NULL
induced	NULL
by	NULL
IFN-	NULL
«	NULL
is	NULL
STAT1I	NULL
.	NULL

Perhaps	NULL
differential	NULL
levels	NULL
of	NULL
expression	NULL
of	NULL
these	NULL
STAT	NULL
's	NULL
can	NULL
explain	NULL
the	NULL
different	NULL
kinetics	NULL
of	NULL
IRF-1	NULL
induction	NULL
.	NULL

FIGURE	NULL
5	NULL
.	NULL

Involvement	NULL
of	NULL
STAT4	NULL
in	NULL
IL-12	NULL
regulation	NULL
of	NULL
IRF-1	NULL
.	NULL

NIH	NULL
3T3	NULL
«	NULL
By	NULL
A	NULL
cells	NULL
(	NULL
4	NULL
)	NULL
and	NULL
NIH	NULL
3T3	NULL
cells	NULL
or	NULL
NIH	NULL
3T3	NULL
cells	NULL
stably	NULL
transfected	NULL
with	NULL
IL-2R	NULL
subunits	NULL
(	NULL
«	NULL
By	NULL
)	NULL
and	NULL
JAK3	NULL
(	NULL
NIH3T3	NULL
afByJAK3	NULL
)	NULL
(	NULL
B	NULL
)	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
3xGAS-luc	NULL
,	NULL
IL-12RB1	NULL
,	NULL
IL-12RB2	NULL
,	NULL
and	NULL
STAT4	NULL
and	NULL
stimulated	NULL
for	NULL
8	NULL
h	NULL
with	NULL
IL-12	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
,	NULL
IL-2	NULL
(	NULL
1000	NULL
IU/m	NULL
!	NULL
)	NULL

,	NULL
or	NULL
both	NULL
as	NULL
indicated	NULL
.	NULL

C	NULL
,	NULL
Wild-type	NULL
IRF-1	NULL
promoter	NULL
luciferase	NULL
construct	NULL
and	NULL
a	NULL
mutant	NULL
construct	NULL
in	NULL
which	NULL
the	NULL
SBE	NULL
site	NULL
has	NULL
been	NULL
mutated	NULL
.	NULL

These	NULL
luciferase	NULL
reporter	NULL
constructs	NULL
and	NULL
IL-12RfB1	NULL
,	NULL
IL-12RB2	NULL
,	NULL
and	NULL
STATA	NULL
were	NULL
transiently	NULL
transfected	NULL
into	NULL
NIH	NULL
3T3	NULL
cells	NULL
and	NULL
stimulated	NULL
with	NULL
IL-12	NULL
(	NULL
10	NULL
ng/	NULL
ml	NULL
)	NULL
as	NULL
indicated	NULL
.	NULL

D	NULL
,	NULL
NK3.3	NULL
cells	NULL
were	NULL
treated	NULL
B	NULL
with	NULL
medium	NULL
alone	NULL
(	NULL
0	NULL
)	NULL
,	NULL
IL-12	NULL
(	NULL
10	NULL
ng/ml	NULL
)	NULL
,	NULL
or	NULL
IFN-	NULL
(	NULL
100	NULL
U/ml	NULL
)	NULL
for	NULL
15	NULL
min	NULL
.	NULL

Whole-cell	NULL
ly-sates	NULL
were	NULL
prepared	NULL
and	NULL
EMSA	NULL
was	NULL
conducted	NULL
using	NULL
*°P-labeled	NULL
IRF-1	NULL
probe	NULL
(	NULL
Zanes	NULL
1-3	NULL
)	NULL
or	NULL
a	NULL
control	NULL
probe	NULL
(	NULL
lanes	NULL
4-6	NULL
)	NULL
(	NULL
39	NULL
)	NULL
.	NULL

E	NULL
,	NULL
Supershift	NULL
analysis	NULL
was	NULL
conducted	NULL
with	NULL
anti-STAT1	NULL
,	NULL
anti-STAT4	NULL
,	NULL
and	NULL
preimmune	NULL
serum	NULL
,	NULL
using	NULL
the	NULL
IRE-1	NULL
oligonucleotide	NULL
probe	NULL
.	NULL

a-afJAK8	NULL
-	NULL
Light	NULL
units	NULL
/	NULL
ug	NULL
protein	NULL
IL-12R81	NULL
IL-12R82	NULL
30000	NULL
4	NULL
20000	NULL
7	NULL
Light	NULL
units/ug	NULL
protein	NULL
10000	NULL
7	NULL
ILM2	NULL
=	NULL
=	NULL
4	NULL
n	NULL
=	NULL
-	NULL
4	NULL
nog	NULL
s	NULL
s	NULL
n	NULL
+	NULL
+	NULL
>	NULL
++	NULL
IL-2	NULL
-	NULL
-	NULL
<	NULL
4	NULL
-	NULL
>	NULL
BxGAS-Luc	NULL
3xGAS-Luc	NULL
non	NULL
dob	NULL
bob	NULL
bb	NULL
b	NULL
bb	NULL
bob	NULL
+	NULL
nob	NULL
4b	NULL
n	NULL
4	NULL
bob	NULL
bob	NULL
b	NULL
b	NULL
4	NULL
bb	NULL
+	NULL
1	NULL
STATA	NULL
«	NULL
-w.	NULL
css	NULL
=	NULL
+	NULL
+	NULL
>	NULL
>	NULL
+	NULL
>	NULL
IL-12AB2	NULL
-	NULL
>	NULL
>	NULL
>	NULL
>	NULL
>	NULL
>	NULL
7259	NULL
Requirement	NULL
of	NULL
STAT4	NULL
in	NULL
IL-12-mediated	NULL
IRF-1	NULL
induction	NULL
STAT4	NULL
serves	NULL
an	NULL
essential	NULL
role	NULL
in	NULL
transmitting	NULL
some	NULL
but	NULL
not	NULL
all	NULL
IL-12-dependent	NULL
signals	NULL
(	NULL
30	NULL
,	NULL
31	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
STAT4	NULL
was	NULL
involved	NULL
in	NULL
IL-12-induced	NULL
expression	NULL
of	NULL
IRF-1	NULL
,	NULL
we	NULL
assayed	NULL
transactivation	NULL
of	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
driven	NULL
by	NULL
the	NULL
STAT	NULL
binding	NULL
site	NULL
from	NULL
the	NULL
IRF-1	NULL
gene	NULL
(	NULL
22	NULL
)	NULL
.	NULL

Since	NULL
T	NULL
cells	NULL
and	NULL
NK	NULL
cells	NULL
already	NULL
express	NULL
STAT4	NULL
,	NULL
confounding	NULL
any	NULL
conclusions	NULL
,	NULL
we	NULL
performed	NULL
these	NULL
experiments	NULL
in	NULL
fibroblasts	NULL
(	NULL
NIH	NULL
3T3	NULL
)	NULL
specifically	NULL
because	NULL
they	NULL
lack	NULL
STAT4	NULL
.	NULL

NIH	NULL
3T3	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
this	NULL
reporter	NULL
gene	NULL
construct	NULL
along	NULL
with	NULL
cDNAs	NULL
encoding	NULL
STAT4	NULL
and	NULL
IL-12R	NULL
subunits	NULL
.	NULL

As	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
IL-12	NULL
induced	NULL
transactivation	NULL
of	NULL
the	NULL
reporter	NULL
construct	NULL
in	NULL
cells	NULL
transfected	NULL
with	NULL
receptor	NULL
subunits	NULL
and	NULL
STAT4	NULL
,	NULL
but	NULL
not	NULL
in	NULL
cells	NULL
transfected	NULL
with	NULL
receptor	NULL
subunits	NULL
alone	NULL
,	NULL
suggesting	NULL
that	NULL
STAT4	NULL
is	NULL
required	NULL
for	NULL
IL-12-induced	NULL
activation	NULL
of	NULL
the	NULL
IRF-1	NULL
gene	NULL
.	NULL

IL-2	NULL
also	NULL
induced	NULL
transactivation	NULL
of	NULL
the	NULL
luciferase	NULL
reporter	NULL
gene	NULL
in	NULL
NIH	NULL
3T3aByJAK3	NULL
cells	NULL
,	NULL
but	NULL
this	NULL
did	NULL
not	NULL
require	NULL
STAT4	NULL
.	NULL

This	NULL
was	NULL
expected	NULL
,	NULL
as	NULL
IL-2	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
activate	NULL
STAT1	NULL
,	NULL
STAT3	NULL
,	NULL
STAT5a	NULL
,	NULL
and	NULL
STATS5b	NULL
.	NULL

To	NULL
confirm	NULL
that	NULL
IRF-1	NULL
transactivation	NULL
was	NULL
mediated	NULL
by	NULL
STAT4	NULL
,	NULL
we	NULL
transfected	NULL
NIH	NULL
3T3	NULL
cells	NULL
with	NULL
a	NULL
plasmid	NULL
construct	NULL
in	NULL
which	NULL
a	NULL
reporter	NULL
gene	NULL
was	NULL
linked	NULL
to	NULL
a	NULL
fragment	NULL
of	NULL
the	NULL
IRF-1	NULL
gene	NULL
containing	NULL
the	NULL
transcription	NULL
promoter-enhancer	NULL
region	NULL
(	NULL
24	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5C	NULL
,	NULL
this	NULL
promoter	NULL
fragment	NULL
was	NULL
able	NULL
to	NULL
respond	NULL
to	NULL
IL-12	NULL
,	NULL
and	NULL
this	NULL
response	NULL
was	NULL
dependent	NULL
on	NULL
an	NULL
intact	NULL
SBE	NULL
at	NULL
position	NULL
-123	NULL
to	NULL
-113	NULL
,	NULL
as	NULL
indicated	NULL
by	NULL
the	NULL
loss	NULL
of	NULL
IL-12	NULL
sensitivity	NULL
when	NULL
the	NULL
SBE	NULL
was	NULL
specifically	NULL
altered	NULL
by	NULL
mutagenesis	NULL
.	NULL

Importantly	NULL
,	NULL
STAT4	NULL
was	NULL
required	NULL
for	NULL
IL-12	NULL
induction	NULL
of	NULL
the	NULL
IRF-1	NULL
promoter	NULL
.	NULL

C	NULL
IRF-1	NULL
promoter	NULL
C_	NULL
]	NULL
SBE	NULL
|	NULL
ug	NULL
mutant	NULL
SBE	NULL
.	NULL

kB	NULL
Light	NULL
units/ug	NULL
protein	NULL
x1000	NULL
_	NULL
.	NULL

38	NULL
1	NULL
20	NULL
{	NULL
I	NULL
e	NULL
O	NULL
SxGAS-Luc	NULL
IL-12R81	NULL
IL-12	NULL
-o	NULL
+	NULL
~	NULL
-	NULL
+	NULL
=~	NULL
+	NULL
IL-12R82	NULL
STtaAT4	NULL
IL-12RB1/82	NULL
0	NULL
+	NULL
+	NULL
0	NULL
+0	NULL
+0	NULL
0	NULL
+	NULL
+	NULL
STAT4	NULL
=o	NULL
>	NULL
+o	NULL
+0	NULL
o+	NULL
IRE-luc	NULL
__	NULL
IRF-luc	NULL
_	NULL
mSBE/IRF-luc	NULL
.	NULL

0	NULL
__	NULL
D	NULL
cu	NULL
_	NULL
jred	NULL
E	NULL
34	NULL
IL-12	NULL
C	NULL
L42	NULL
Ci	NULL
\	NULL
tum	NULL
-	NULL
stats	NULL
n	NULL
4	NULL
9	NULL
t	NULL
n	NULL
4	NULL
n+	NULL
2	NULL
3	NULL
4	NULL
-A	NULL
49	NULL
0	NULL
%	NULL
440	NULL
%	NULL
non	NULL
n	NULL
b	NULL
dot	NULL
444	NULL
non	NULL
n	NULL
dod	NULL
4	NULL
odd	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
7260	NULL
We	NULL
next	NULL
sought	NULL
to	NULL
determine	NULL
whether	NULL
we	NULL
could	NULL
demonstrate	NULL
binding	NULL
of	NULL
STAT4	NULL
to	NULL
the	NULL
human	NULL
IRF-1	NULL
promoter	NULL
using	NULL
EMSA	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

5D	NULL
,	NULL
stimulation	NULL
of	NULL
NK3.3	NULL
cells	NULL
with	NULL
IL-12	NULL
resulted	NULL
in	NULL
formation	NULL
of	NULL
DNA	NULL
binding	NULL
complexes	NULL
with	NULL
the	NULL
human	NULL
IRF-1	NULL
promoter	NULL
.	NULL

These	NULL
complexes	NULL
were	NULL
specific	NULL
because	NULL
they	NULL
were	NULL
present	NULL
in	NULL
the	NULL
stimulated	NULL
cell	NULL
only	NULL
(	NULL
Fig	NULL
.	NULL

5D	NULL
,	NULL
lane	NULL
4	NULL
vs	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
were	NULL
formed	NULL
with	NULL
the	NULL
IRF-1	NULL
probe	NULL
but	NULL
not	NULL
with	NULL
the	NULL
control	NULL
probe	NULL
(	NULL
Ct	NULL
!	NULL
)	NULL

(	NULL
Fig	NULL
.	NULL

5D	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
and	NULL
were	NULL
abolished	NULL
with	NULL
an	NULL
excess	NULL
of	NULL
unlabeled	NULL
IRF-1	NULL
probe	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Supershift	NULL
experiments	NULL
(	NULL
Fig	NULL
.	NULL

5€	NULL
)	NULL
with	NULL
anti-STAT4	NULL
Abs	NULL
showed	NULL
that	NULL
the	NULL
EMSA	NULL
signal	NULL
detected	NULL
after	NULL
IL-12	NULL
stimulation	NULL
contained	NULL
STAT4	NULL
complexes	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

A	NULL
control	NULL
Ab	NULL
(	NULL
Ct	NULL
)	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
pattern	NULL
of	NULL
the	NULL
complexes	NULL
(	NULL
Fig	NULL
.	NULL

lane	NULL
4	NULL
)	NULL
,	NULL
and	NULL
none	NULL
of	NULL
the	NULL
Abs	NULL
had	NULL
an	NULL
effect	NULL
on	NULL
the	NULL
unstimulated	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

IL-4	NULL
does	NULL
not	NULL
up-regulate	NULL
IRF-1	NULL
expression	NULL
and	NULL
fails	NULL
to	NULL
inhibit	NULL
IL-12-dependent	NULL
up-regulation	NULL
of	NULL
IRF-1	NULL
The	NULL
phenotype	NULL
of	NULL
IRF-1	NULL
~*~	NULL
mice	NULL
indicates	NULL
that	NULL
IRF-1	NULL
is	NULL
important	NULL
for	NULL
Th1	NULL
differentiation	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
IL-12	NULL
,	NULL
IL-4	NULL
promotes	NULL
Th2	NULL
responses	NULL
;	NULL
therefore	NULL
,	NULL
we	NULL
next	NULL
sought	NULL
to	NULL
determine	NULL
whether	NULL
IL-4	NULL
also	NULL
regulated	NULL
IRF-1	NULL
expression	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
IL-4	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
inhibit	NULL
IL-12-dependent	NULL
induction	NULL
of	NULL
IFN-y	NULL
(	NULL
32	NULL
)	NULL
and	NULL
to	NULL
inhibit	NULL
IFN-y-dependent	NULL
up-regulation	NULL
of	NULL
IRF-1	NULL
(	NULL
24	NULL
)	NULL
.	NULL

We	NULL
therefore	NULL
also	NULL
analyzed	NULL
whether	NULL
IL-4	NULL
blocked	NULL
IL-12-dependent	NULL
IRF-1	NULL
induction	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
whereas	NULL
IL-12	NULL
up-regulated	NULL
IRF-1	NULL
(	NULL
Zane	NULL
2	NULL
)	NULL
,	NULL
no	NULL
up-regulation	NULL
of	NULL
IRF-1	NULL
was	NULL
found	NULL
in	NULL
IL-4-stimulated	NULL
cells	NULL
(	NULL
Jane	NULL
3	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
found	NULL
using	NULL
T	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

IL-4	NULL
was	NULL
active	NULL
,	NULL
since	NULL
it	NULL
induced	NULL
the	NULL
expression	NULL
of	NULL
IL-4R	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
and	NULL
inhibited	NULL
the	NULL
IL-12	NULL
induction	NULL
of	NULL
IFN-y	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
IL-4	NULL
treatment	NULL
did	NULL
not	NULL
block	NULL
IL-12-dependent	NULL
up-regulation	NULL
of	NULL
IRF-1	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

These	NULL
data	NULL
are	NULL
important	NULL
because	NULL
they	NULL
not	NULL
only	NULL
indicate	NULL
that	NULL
a	NULL
Th2	NULL
cytokine	NULL
does	NULL
not	NULL
induce	NULL
IRF-1	NULL
but	NULL
also	NULL
because	NULL
they	NULL
confirm	NULL
that	NULL
IL-12	NULL
directly	NULL
up-regulates	NULL
IRF-1	NULL
.	NULL

That	NULL
is	NULL
,	NULL
although	NULL
IL-4	NULL
inhibited	NULL
IL-1	NULL
IFN-y	NULL
production	NULL
,	NULL
IL-12-dependent	NULL
up-regulation	NULL
of	NULL
IRF-1	NULL
was	NULL
unaf-fected	NULL
.	NULL

This	NULL
further	NULL
demonstrates	NULL
that	NULL
the	NULL
IL-12-mediated	NULL
induction	NULL
of	NULL
IRF-1	NULL
is	NULL
independent	NULL
of	NULL
IFN-y	NULL
.	NULL

Discussion	NULL
IL-12	NULL
is	NULL
a	NULL
critical	NULL
immunoregulatory	NULL
cytokine	NULL
implicated	NULL
in	NULL
multiple	NULL
steps	NULL
of	NULL
Th1	NULL
differentiation	NULL
.	NULL

However	NULL
,	NULL
the	NULL
similarity	NULL
in	NULL
some	NULL
aspects	NULL
of	NULL
IFN-a	NULL
«	NULL
and	NULL
IL-12	NULL
signaling	NULL
suggested	NULL
that	NULL
these	NULL
cytokines	NULL
may	NULL
regulate	NULL
some	NULL
genes	NULL
in	NULL
common	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
importance	NULL
of	NULL
IFN-a	NULL
@	NULL
as	NULL
an	NULL
immunoregulatory	NULL
cytokine	NULL
has	NULL
been	NULL
suggested	NULL
by	NULL
several	NULL
findings	NULL
.	NULL

First	NULL
,	NULL
IFN-a	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
increase	NULL
the	NULL
frequency	NULL
of	NULL
IFN-y-secreting	NULL
CD4	NULL
Th	NULL
cells	NULL
and	NULL
therefore	NULL
favors	NULL
the	NULL
induction	NULL
of	NULL
Th1	NULL
cells	NULL
(	NULL
33	NULL
)	NULL
.	NULL

Second	NULL
,	NULL
IL-12R	NULL
B2	NULL
subunit	NULL
,	NULL
which	NULL
is	NULL
expressed	NULL
only	NULL
on	NULL
Th1	NULL
but	NULL
not	NULL
Th2	NULL
clones	NULL
,	NULL
is	NULL
induced	NULL
by	NULL
IL-12	NULL
and	NULL
IFN-a	NULL
during	NULL
differentiation	NULL
of	NULL
human	NULL
naive	NULL
cells	NULL
along	NULL
the	NULL
Th1	NULL
but	NULL
not	NULL
Th2	NULL
pathway	NULL
(	NULL
34	NULL
)	NULL
.	NULL

For	NULL
these	NULL
reasons	NULL
we	NULL
thought	NULL
it	NULL
important	NULL
to	NULL
begin	NULL
cataloging	NULL
genes	NULL
induced	NULL
uniquely	NULL
and	NULL
commonly	NULL
by	NULL
IL-12	NULL
and	NULL
IFN-	NULL
.	NULL

We	NULL
show	NULL
here	NULL
that	NULL
IL-12	NULL
up-regulated	NULL
some	NULL
genes	NULL
(	NULL
MIP-1	NULL
@	NULL
,	NULL
MIP-1	NULL
$	NULL
3	NULL
,	NULL
and	NULL
IL-1RA	NULL
)	NULL
that	NULL
had	NULL
previously	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
up-regulated	NULL
by	NULL
IFN-	NULL
«	NULL
.	NULL

Interestingly	NULL
,	NULL
it	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
Th1	NULL
but	NULL
not	NULL
Th2	NULL
cells	NULL
produce	NULL
MIP-1	NULL
«	NULL
,	NULL
MIP-18	NULL
(	NULL
35	NULL
)	NULL
,	NULL
and	NULL
IL-1RA	NULL
(	NULL
36	NULL
)	NULL
,	NULL
and	NULL
that	NULL
these	NULL
chemokines	NULL
are	NULL
efficient	NULL
chemoattractants	NULL
specifically	NULL
for	NULL
Th1	NULL
cells	NULL
,	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Conversely	NULL
,	NULL
although	NULL
granzyme	NULL
B	NULL
is	NULL
recognized	NULL
as	NULL
an	NULL
IL-12-inducible	NULL
gene	NULL
,	NULL
IFN-a	NULL
also	NULL
up-regulated	NULL
this	NULL
gene	NULL
.	NULL

Additionally	NULL
,	NULL
although	NULL
RVP1	NULL
was	NULL
not	NULL
previously	NULL
recognized	NULL
INDUCTION	NULL
OF	NULL
IRF-1	NULL
BY	NULL
IL-12	NULL
AND	NULL
IL-2	NULL
,	NULL
BUT	NULL
NOT	NULL
BY	NULL
IL-4	NULL
ike	NULL
hud	NULL
.	NULL

IRF-1	NULL
®	NULL
»	NULL
ag	NULL
-~	NULL
«	NULL
*	NULL
IFNy	NULL
Woot	NULL
m	NULL
oan	NULL
L32	NULL
woah	NULL
tin	NULL
ae	NULL
GAPDH	NULL
ciel	NULL
**	NULL
)	NULL
)	NULL
1E-4	NULL
FIGURE	NULL
6	NULL
.	NULL

IL-4	NULL
does	NULL
not	NULL
up-regulate	NULL
IRF-1	NULL
and	NULL
fails	NULL
to	NULL
inhibit	NULL
IL-12	NULL
up-regulation	NULL
of	NULL
IRF-1	NULL
.	NULL

NK3.3	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
4	NULL
h	NULL
with	NULL
IL-4	NULL
(	NULL
1000	NULL
IU/ml	NULL
)	NULL
,	NULL
IL-12	NULL
(	NULL
10	NULL
ng/m	NULL
!	NULL
)	NULL

,	NULL
or	NULL
a	NULL
combination	NULL
of	NULL
both	NULL
(	NULL
with	NULL
IL-4	NULL
being	NULL
added	NULL
15	NULL
min	NULL
before	NULL
IL-12	NULL
addition	NULL
)	NULL
.	NULL

RNA	NULL
was	NULL
prepared	NULL
,	NULL
and	NULL
the	NULL
RNase	NULL
protection	NULL
assay	NULL
was	NULL
conducted	NULL
using	NULL
radiolabeled	NULL
IRF-1	NULL
,	NULL
IFN-y	NULL
,	NULL
and	NULL
GAPDH	NULL
and	NULL
L32	NULL
probes	NULL
.	NULL

as	NULL
being	NULL
regulated	NULL
by	NULL
either	NULL
IL-12	NULL
or	NULL
IFN-a	NULL
,	NULL
its	NULL
expression	NULL
was	NULL
regulated	NULL
by	NULL
both	NULL
of	NULL
these	NULL
cytokines	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
GBP	NULL
,	NULL
ISG15	NULL
,	NULL
and	NULL
ISG54	NULL
,	NULL
each	NULL
of	NULL
which	NULL
contains	NULL
IFN-stimulation	NULL
response	NULL
element	NULL
in	NULL
its	NULL
promoter	NULL
region	NULL
,	NULL
were	NULL
specific	NULL
for	NULL
IFN-	NULL
.	NULL

We	NULL
also	NULL
report	NULL
that	NULL
IL-12	NULL
,	NULL
as	NULL
well	NULL
as	NULL
IL-2	NULL
,	NULL
induced	NULL
IRF-1	NULL
gene	NULL
expression	NULL
.	NULL

While	NULL
IRF-1	NULL
knockout	NULL
mice	NULL
have	NULL
a	NULL
profound	NULL
defect	NULL
in	NULL
Th1	NULL
development	NULL
and	NULL
cell-mediated	NULL
responses	NULL
,	NULL
the	NULL
mechanisms	NULL
underlying	NULL
this	NULL
defect	NULL
are	NULL
only	NULL
partly	NULL
understood	NULL
.	NULL

IL-12	NULL
is	NULL
critical	NULL
for	NULL
cell-mediated	NULL
immunity	NULL
,	NULL
and	NULL
IRF-1	NULL
likely	NULL
contributes	NULL
to	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
IL-12p40	NULL
gene	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
a	NULL
major	NULL
source	NULL
of	NULL
IFN-y	NULL
in	NULL
the	NULL
initial	NULL
phase	NULL
of	NULL
the	NULL
Th1	NULL
response	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
NK	NULL
cells	NULL
(	NULL
1	NULL
)	NULL
,	NULL
and	NULL
IRF-1~'~	NULL
mice	NULL
have	NULL
impaired	NULL
NK	NULL
cell	NULL
development	NULL
.	NULL

This	NULL
may	NULL
be	NULL
because	NULL
IRF-1	NULL
contributes	NULL
to	NULL
IL-15	NULL
gene	NULL
regulation	NULL
and	NULL
IL-15	NULL
is	NULL
important	NULL
in	NULL
NK	NULL
cell	NULL
differentiation	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
poor	NULL
IFN-y	NULL
production	NULL
in	NULL
IRF-1	NULL
~~	NULL
is	NULL
related	NULL
in	NULL
part	NULL
to	NULL
the	NULL
absence	NULL
of	NULL
IL-12	NULL
and	NULL
to	NULL
the	NULL
lack	NULL
of	NULL
NK	NULL
cells	NULL
.	NULL

But	NULL
does	NULL
this	NULL
completely	NULL
explain	NULL
the	NULL
Th1	NULL
defect	NULL
in	NULL
IRF-1~'~	NULL
mice	NULL
?	NULL

The	NULL
answer	NULL
appears	NULL
to	NULL
be	NULL
no	NULL
,	NULL
because	NULL
IRF-1~'~-	NULL
mice	NULL
have	NULL
also	NULL
been	NULL
shown	NULL
to	NULL
have	NULL
impaired	NULL
responses	NULL
to	NULL
IL-12	NULL
(	NULL
18	NULL
,	NULL
19	NULL
)	NULL
.	NULL

Stimulation	NULL
of	NULL
CD4*	NULL
T	NULL
cells	NULL
from	NULL
IRF-1~'~	NULL
mice	NULL
with	NULL
IL-12	NULL
induces	NULL
substantially	NULL
less	NULL
IFN-y	NULL
than	NULL
wild	NULL
type	NULL
,	NULL
even	NULL
though	NULL
expression	NULL
of	NULL
IL-12R	NULL
$	NULL
1	NULL
and	NULL
IL-12Rf32	NULL
is	NULL
reportedly	NULL
normal	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
was	NULL
suggested	NULL
that	NULL
impaired	NULL
IL-12	NULL
production	NULL
in	NULL
IRF-1~'~-	NULL
mice	NULL
alone	NULL
does	NULL
not	NULL
account	NULL
for	NULL
the	NULL
Th2-dominant	NULL
response	NULL
observed	NULL
.	NULL

Based	NULL
on	NULL
the	NULL
present	NULL
results	NULL
,	NULL
it	NULL
can	NULL
be	NULL
proposed	NULL
that	NULL
the	NULL
IL-12-up-regu-lation	NULL
of	NULL
IRF-1	NULL
is	NULL
important	NULL
for	NULL
the	NULL
action	NULL
of	NULL
this	NULL
cytokine	NULL
;	NULL
the	NULL
unresponsiveness	NULL
of	NULL
IRF-1	NULL
~~	NULL
mice	NULL
to	NULL
IL-12	NULL
may	NULL
be	NULL
related	NULL
in	NULL
part	NULL
to	NULL
the	NULL
lack	NULL
of	NULL
up-regulation	NULL
of	NULL
this	NULL
transcription	NULL
factor	NULL
.	NULL

It	NULL
is	NULL
important	NULL
to	NULL
emphasize	NULL
,	NULL
however	NULL
,	NULL
that	NULL
our	NULL
findings	NULL
in	NULL
an	NULL
NK	NULL
cell	NULL
line	NULL
and	NULL
peripheral	NULL
blood	NULL
T	NULL
cells	NULL
may	NULL
not	NULL
directly	NULL
relate	NULL
to	NULL
the	NULL
process	NULL
of	NULL
Th1	NULL
development	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
while	NULL
our	NULL
results	NULL
that	NULL
IL-12	NULL
induces	NULL
IRF-1	NULL
expression	NULL
may	NULL
shed	NULL
light	NULL
on	NULL
the	NULL
defective	NULL
IL-12	NULL
responses	NULL
in	NULL
IRF-1~'~-	NULL
mice	NULL
,	NULL
IL-12	NULL
target	NULL
genes	NULL
are	NULL
still	NULL
poorly	NULL
characterized	NULL
,	NULL
and	NULL
it	NULL
is	NULL
not	NULL
immediately	NULL
clear	NULL
how	NULL
IRF-1	NULL
contributes	NULL
to	NULL
IL-12	NULL
signaling	NULL
.	NULL

Nonetheless	NULL
,	NULL
our	NULL
results	NULL
clearly	NULL
indicate	NULL
that	NULL
IL-12	NULL
and	NULL
IFN-a	NULL
@	NULL
activate	NULL
a	NULL
number	NULL
of	NULL
genes	NULL
in	NULL
common	NULL
,	NULL
including	NULL
the	NULL
transcription	NULL
factor	NULL
IREF-1	NULL
.	NULL

CHX	NULL
did	NULL
not	NULL
inhibit	NULL
IL-12	NULL
(	NULL
nor	NULL
IL-2	NULL
)	NULL
-induced	NULL
IRF-1	NULL
expression	NULL
,	NULL
which	NULL
emphasize	NULL
the	NULL
direct	NULL
6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
role	NULL
of	NULL
these	NULL
cytokines	NULL
in	NULL
the	NULL
up-regulation	NULL
of	NULL
IRF-1	NULL
.	NULL

Indeed	NULL
,	NULL
CHX	NULL
enhanced	NULL
the	NULL
IRF-1	NULL
induction	NULL
mediated	NULL
by	NULL
IL-12	NULL
.	NULL

What	NULL
this	NULL
labile	NULL
inhibitor	NULL
of	NULL
IRF-1	NULL
expression	NULL
is	NULL
remains	NULL
obscure	NULL
.	NULL

Whether	NULL
members	NULL
of	NULL
the	NULL
PIAS	NULL
family	NULL
or	NULL
the	NULL
CIS/SOCS/JAB/SSI	NULL
family	NULL
contribute	NULL
to	NULL
this	NULL
inhibition	NULL
is	NULL
unknown	NULL
but	NULL
is	NULL
presently	NULL
under	NULL
inves-tigation	NULL
.	NULL

Another	NULL
possible	NULL
interpretation	NULL
would	NULL
be	NULL
that	NULL
IL-12	NULL
mediates	NULL
its	NULL
effect	NULL
on	NULL
the	NULL
IRF-1	NULL
gene	NULL
by	NULL
message	NULL
by	NULL
inhibiting	NULL
a	NULL
degradative	NULL
enzyme	NULL
.	NULL

Since	NULL
there	NULL
is	NULL
no	NULL
superinduction	NULL
of	NULL
IRF-1	NULL
by	NULL
IL-2	NULL
,	NULL
it	NULL
could	NULL
postulated	NULL
that	NULL
IL-2	NULL
is	NULL
acting	NULL
on	NULL
the	NULL
transcriptional	NULL
level	NULL
,	NULL
while	NULL
IL-12	NULL
acts	NULL
on	NULL
the	NULL
posttranscriptional	NULL
level	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
STAT4	NULL
is	NULL
essential	NULL
for	NULL
many	NULL
IL-12	NULL
effects	NULL
and	NULL
is	NULL
required	NULL
for	NULL
the	NULL
Th1	NULL
response	NULL
(	NULL
30	NULL
,	NULL
31	NULL
)	NULL
.	NULL

We	NULL
show	NULL
here	NULL
that	NULL
STAT4	NULL
appears	NULL
to	NULL
be	NULL
important	NULL
for	NULL
the	NULL
IL-12-dependent	NULL
regulation	NULL
of	NULL
IRF-1	NULL
.	NULL

We	NULL
have	NULL
demonstrated	NULL
that	NULL
IRF-1	NULL
transactivation	NULL
by	NULL
IL-12	NULL
was	NULL
mediated	NULL
by	NULL
STAT4	NULL
binding	NULL
and	NULL
that	NULL
the	NULL
SBE	NULL
present	NULL
on	NULL
the	NULL
IRF-1	NULL
promoter-enhancer	NULL
region	NULL
was	NULL
necessary	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
and	NULL
sufficient	NULL
(	NULL
Fig	NULL
.	NULL

54	NULL
)	NULL
for	NULL
the	NULL
IRF-1	NULL
induction	NULL
.	NULL

We	NULL
used	NULL
fibroblasts	NULL
in	NULL
our	NULL
studies	NULL
because	NULL
they	NULL
lack	NULL
STAT4	NULL
and	NULL
thus	NULL
provide	NULL
a	NULL
useful	NULL
vehicle	NULL
for	NULL
testing	NULL
STAT4	NULL
dependence	NULL
of	NULL
IL-12	NULL
transactivation	NULL
of	NULL
the	NULL
IRF-1	NULL
promoter	NULL
construct	NULL
.	NULL

Clearly	NULL
,	NULL
though	NULL
,	NULL
these	NULL
results	NULL
need	NULL
to	NULL
be	NULL
verified	NULL
in	NULL
a	NULL
more	NULL
physiologic	NULL
system	NULL
.	NULL

That	NULL
STAT4	NULL
has	NULL
the	NULL
capacity	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
IRF-1	NULL
promoter	NULL
has	NULL
been	NULL
recognized	NULL
since	NULL
the	NULL
cloning	NULL
of	NULL
STAT4	NULL
.	NULL

In	NULL
the	NULL
initial	NULL
studies	NULL
,	NULL
STAT4	NULL
was	NULL
shown	NULL
to	NULL
bind	NULL
the	NULL
IFN-y	NULL
activation	NULL
site	NULL
(	NULL
GAS	NULL
)	NULL
element	NULL
of	NULL
the	NULL
murine	NULL
IRF-1	NULL
promoter	NULL
(	NULL
38	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
significance	NULL
of	NULL
this	NULL
result	NULL
was	NULL
not	NULL
pursued	NULL
at	NULL
that	NULL
time	NULL
,	NULL
our	NULL
data	NULL
confirm	NULL
that	NULL
STAT4	NULL
binds	NULL
the	NULL
human	NULL
promoter	NULL
.	NULL

Whether	NULL
IRF-1	NULL
and	NULL
STAT4	NULL
function	NULL
in	NULL
concert	NULL
to	NULL
effect	NULL
gene	NULL
regulation	NULL
or	NULL
in	NULL
parallel	NULL
by	NULL
activating	NULL
different	NULL
sets	NULL
of	NULL
target	NULL
genes	NULL
has	NULL
yet	NULL
to	NULL
be	NULL
determined	NULL
.	NULL

Identification	NULL
of	NULL
target	NULL
genes	NULL
of	NULL
IRF-1	NULL
and	NULL
STAT4	NULL
after	NULL
IL-12	NULL
stimulation	NULL
will	NULL
clarify	NULL
this	NULL
issue	NULL
and	NULL
help	NULL
us	NULL
to	NULL
understand	NULL
the	NULL
gene-regulatory	NULL
events	NULL
mediating	NULL
Th1/Th2	NULL
differentiation	NULL
.	NULL

Comparing	NULL
and	NULL
contrasting	NULL
IL-12-dependent	NULL
gene	NULL
expression	NULL
in	NULL
IRF-1~'~	NULL
and	NULL
STAT4~'~	NULL
mice	NULL
will	NULL
be	NULL
of	NULL
considerable	NULL
interest	NULL
in	NULL
this	NULL
regard	NULL
.	NULL

It	NULL
should	NULL
be	NULL
noted	NULL
that	NULL
the	NULL
IL-2-mediated	NULL
induction	NULL
of	NULL
IRF-1	NULL
was	NULL
,	NULL
predictably	NULL
,	NULL
not	NULL
dependent	NULL
on	NULL
STAT4	NULL
.	NULL

Similarly	NULL
,	NULL
although	NULL
IFN-a	NULL
can	NULL
activate	NULL
STAT4	NULL
,	NULL
we	NULL
have	NULL
no	NULL
data	NULL
indicating	NULL
that	NULL
STAT4	NULL
is	NULL
important	NULL
for	NULL
IFN-a-dependent	NULL
IRF-1	NULL
regulation	NULL
;	NULL
STAT1	NULL
is	NULL
likely	NULL
to	NULL
be	NULL
more	NULL
relevant	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
IL-12	NULL
,	NULL
IL-4	NULL
promotes	NULL
Th2	NULL
responses	NULL
.	NULL

IL-4	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
inhibit	NULL
IL-12-dependent	NULL
induction	NULL
of	NULL
IFN-y	NULL
(	NULL
32	NULL
)	NULL
and	NULL
to	NULL
inhibit	NULL
IFN-y-dependent	NULL
up-regulation	NULL
of	NULL
IRF-1	NULL
(	NULL
24	NULL
)	NULL
.	NULL

Based	NULL
on	NULL
the	NULL
phenotype	NULL
of	NULL
IRF-1	NULL
~~	NULL
mice	NULL
,	NULL
IRF-1	NULL
appears	NULL
to	NULL
participate	NULL
in	NULL
Th1	NULL
differentiation	NULL
,	NULL
and	NULL
interestingly	NULL
,	NULL
no	NULL
up-regulation	NULL
of	NULL
IRF-1	NULL
was	NULL
found	NULL
in	NULL
IL-4-stimulated	NULL
cells	NULL
.	NULL

Importantly	NULL
,	NULL
IL-4	NULL
treatment	NULL
did	NULL
not	NULL
block	NULL
IL-12-dependent	NULL
up-regulation	NULL
of	NULL
IRF-1	NULL
,	NULL
and	NULL
this	NULL
contrasts	NULL
with	NULL
the	NULL
induction	NULL
of	NULL
IFN-y	NULL
by	NULL
IL-12	NULL
.	NULL

The	NULL
experiment	NULL
thus	NULL
substantiates	NULL
our	NULL
claim	NULL
that	NULL
IL-12-dependent	NULL
up-regulation	NULL
of	NULL
IRF-1	NULL
was	NULL
not	NULL
indirectly	NULL
mediated	NULL
by	NULL
IFN-y	NULL
production	NULL
,	NULL
as	NULL
IL-4	NULL
blocked	NULL
IFN-y	NULL
induction	NULL
but	NULL
not	NULL
IRF-1	NULL
.	NULL

In	NULL
conclusion	NULL
,	NULL
we	NULL
have	NULL
demonstrated	NULL
that	NULL
IL-12	NULL
and	NULL
IFN-a	NULL
up-regulate	NULL
a	NULL
number	NULL
of	NULL
genes	NULL
in	NULL
common	NULL
.	NULL

One	NULL
important	NULL
gene	NULL
known	NULL
to	NULL
be	NULL
regulated	NULL
by	NULL
IFN-a	NULL
is	NULL
IRF-1	NULL
,	NULL
but	NULL
it	NULL
too	NULL
is	NULL
directly	NULL
regulated	NULL
by	NULL
IL-12	NULL
and	NULL
IL-2	NULL
,	NULL
but	NULL
not	NULL
by	NULL
IL-4	NULL
.	NULL

Thus	NULL
,	NULL
IRF-1	NULL
can	NULL
also	NULL
be	NULL
viewed	NULL
as	NULL
a	NULL
gene	NULL
that	NULL
is	NULL
regulated	NULL
by	NULL
Th1	NULL
cytokines	NULL
.	NULL

The	NULL
demonstration	NULL
that	NULL
IL-12	NULL
induces	NULL
IRF-1	NULL
expression	NULL
may	NULL
help	NULL
to	NULL
clarify	NULL
the	NULL
defects	NULL
found	NULL
in	NULL
IRF-1~'~-	NULL
mice	NULL
;	NULL
loss	NULL
of	NULL
this	NULL
transcription	NULL
factor	NULL
not	NULL
only	NULL
interferes	NULL
with	NULL
IL-12	NULL
and	NULL
IL-15	NULL
synthesis	NULL
but	NULL
may	NULL
interfere	NULL
with	NULL
some	NULL
of	NULL
the	NULL
actions	NULL
of	NULL
IL-12	NULL
and	NULL
IL-2	NULL
.	NULL

To	NULL
what	NULL
extent	NULL
IRF-1	NULL
serves	NULL
as	NULL
an	NULL
IL-12-dependent	NULL
transcription	NULL
factor	NULL
will	NULL
be	NULL
better	NULL
appreciated	NULL
as	NULL
we	NULL
learn	NULL
more	NULL
about	NULL
the	NULL
genes	NULL
induced	NULL
by	NULL
these	NULL
cytokines	NULL
.	NULL

7261	NULL
Acknowledgements	NULL
We	NULL
thank	NULL
Drs	NULL
.	NULL

Richard	NULL
Pine	NULL
,	NULL
Ueli	NULL
Gubler	NULL
,	NULL
and	NULL
James	NULL
Ihle	NULL
for	NULL
providing	NULL
reagents	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Dr.	NULL
Dave	NULL
Frucht	NULL
and	NULL
Keiko	NULL
Ozato	NULL
for	NULL
reading	NULL
the	NULL
manuscript	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Trinchieri	NULL
,	NULL
G.	NULL
1995	NULL
.	NULL

Interleukin-12	NULL
:	NULL
a	NULL
proinflammatory	NULL
cytokine	NULL
with	NULL
immunoregulatory	NULL
functions	NULL
that	NULL
bridge	NULL
innate	NULL
resistance	NULL
and	NULL
antigen-specific	NULL
adaptive	NULL
immunity	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

13:251	NULL
.	NULL

2	NULL
.	NULL

Magram	NULL
,	NULL
J.	NULL
,	NULL
S.	NULL
E.	NULL
Connaughton	NULL
,	NULL
R.	NULL
R.	NULL
Warrier	NULL
,	NULL
D.	NULL
M.	NULL
Carvajal	NULL
,	NULL
C.	NULL
Y.	NULL
Wu	NULL
,	NULL
J.	NULL
Ferrante	NULL
,	NULL
C.	NULL
Stewart	NULL
,	NULL
U.	NULL
Sarmiento	NULL
,	NULL
D.	NULL
A.	NULL
Faherty	NULL
,	NULL
and	NULL
M.	NULL
K.	NULL
Gately	NULL
.	NULL

1996	NULL
.	NULL

IL-12-deficient	NULL
mice	NULL
are	NULL
defective	NULL
in	NULL
IFN-y	NULL
production	NULL
and	NULL
type	NULL
1	NULL
cytokine	NULL
responses	NULL
.	NULL

Immunity	NULL
4:471	NULL
.	NULL

3	NULL
.	NULL

Bacon	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
D.	NULL
W.	NULL
McVicar	NULL
,	NULL
J.	NULL
R.	NULL
Ortaldo	NULL
,	NULL
R.	NULL
C.	NULL
Rees	NULL
,	NULL
J.	NULL
J.	NULL
O'Shea	NULL
,	NULL
and	NULL
J	NULL
.	NULL

A.	NULL
Johnston	NULL
.	NULL

1995	NULL
.	NULL

Interleukin	NULL
12	NULL
(	NULL
IL-12	NULL
)	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK2	NULL
and	NULL
TYK2	NULL
:	NULL
differential	NULL
use	NULL
of	NULL
Janus	NULL
family	NULL
tyrosine	NULL
kinases	NULL
by	NULL
IL-2	NULL
and	NULL
IL-12	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

181:399	NULL
.	NULL

4	NULL
.	NULL

Gollob	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
E.	NULL
A.	NULL
Murphy	NULL
,	NULL
S.	NULL
Mahajan	NULL
,	NULL
C.	NULL
P.	NULL
Schnipper	NULL
,	NULL
J.	NULL
Ritz	NULL
,	NULL
and	NULL
D.	NULL
A.	NULL
Frank	NULL
.	NULL

1998	NULL
.	NULL

Altered	NULL
interleukin-12	NULL
responsiveness	NULL
in	NULL
Th1	NULL
and	NULL
Th2	NULL
cells	NULL
is	NULL
associated	NULL
with	NULL
the	NULL
differential	NULL
activation	NULL
of	NULL
STATS	NULL
and	NULL
STAT1	NULL
.	NULL

Blood	NULL
91:1341	NULL
.	NULL

5	NULL
.	NULL

Bacon	NULL
,	NULL
C.	NULL
M.	NULL
,	NULL
E.	NULL
F.	NULL
R.	NULL
Petricoin	NULL
,	NULL
J.	NULL
R.	NULL
Ortaldo	NULL
,	NULL
R.	NULL
C.	NULL
Rees	NULL
,	NULL
A.	NULL
C.	NULL
Larner	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Johnston	NULL
,	NULL
and	NULL
J.	NULL
J.	NULL
O'Shea	NULL
.	NULL

1995	NULL
.	NULL

Interleukin	NULL
12	NULL
induces	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
STAT4	NULL
in	NULL
human	NULL
lymphocytes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:7307	NULL
.	NULL

6	NULL
.	NULL

Jacobson	NULL
,	NULL
N.	NULL
G.	NULL
,	NULL
S.	NULL
J.	NULL
Szabo	NULL
,	NULL
R.	NULL
M.	NULL
Weber-Nordt	NULL
,	NULL
Z.	NULL
Zhong	NULL
,	NULL
R.	NULL
D.	NULL
Schreiber	NULL
,	NULL
J.	NULL
E.	NULL
J.	NULL
Damell	NULL
,	NULL
and	NULL
K.	NULL
M.	NULL
Murphy	NULL
.	NULL

1995	NULL
.	NULL

Interleukin	NULL
12	NULL
signaling	NULL
in	NULL
T	NULL
helper	NULL
type	NULL
1	NULL
(	NULL
Th1	NULL
)	NULL
cells	NULL
involves	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
signal	NULL
transducer	NULL
and	NULL
activator	NULL
of	NULL
transcription	NULL
(	NULL
Stat	NULL
)	NULL
3	NULL
and	NULL
Stad	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

181:1755	NULL
.	NULL

7	NULL
.	NULL

Damell	NULL
,	NULL
J.	NULL
E.	NULL
J	NULL
.	NULL

1997	NULL
.	NULL

STATs	NULL
and	NULL
gene	NULL
regulation	NULL
.	NULL

Science	NULL
277:1630	NULL
.	NULL

8	NULL
.	NULL

Schindler	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
J.	NULL
Darnell	NULL
.	NULL

1995	NULL
.	NULL

Transcriptional	NULL
responses	NULL
to	NULL
polypeptide	NULL
ligands	NULL
:	NULL
the	NULL
JAK-STAT	NULL
pathway	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

64:621	NULL
.	NULL

9	NULL
.	NULL

Boehm	NULL
,	NULL
U.	NULL
,	NULL
T.	NULL
Klamp	NULL
,	NULL
M.	NULL
Groot	NULL
,	NULL
and	NULL
J.	NULL
C.	NULL
Howard	NULL
.	NULL

1997	NULL
.	NULL

Cellular	NULL
responses	NULL
to	NULL
interferon-y	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

15:749	NULL
.	NULL

10	NULL
.	NULL

Cho	NULL
,	NULL
S.	NULL
S.	NULL
,	NULL
C.	NULL
M.	NULL
Bacon	NULL
,	NULL
C.	NULL
Sudarshan	NULL
,	NULL
R.	NULL
C.	NULL
Rees	NULL
,	NULL
D.	NULL
Finbloom	NULL
,	NULL
R.	NULL
Pine	NULL
,	NULL
and	NULL
J.	NULL
J.	NULL
O'Shea	NULL
.	NULL

1996	NULL
.	NULL

Activation	NULL
of	NULL
STAT4	NULL
by	NULL
IL-12	NULL
and	NULL
IFN-	NULL
@	NULL
:	NULL
evidence	NULL
for	NULL
the	NULL
involvement	NULL
of	NULL
ligand-induced	NULL
tyrosine	NULL
and	NULL
serine	NULL
phosphorylation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

157:4781	NULL
.	NULL

11	NULL
.	NULL

Leonard	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
and	NULL
J.	NULL
J.	NULL
O	NULL
'	NULL
Shea	NULL
.	NULL

1998	NULL
.	NULL

Jaks	NULL
and	NULL
STATs	NULL
:	NULL
biological	NULL
implications	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

16:293	NULL
.	NULL

12	NULL
.	NULL

Miyamoto	NULL
,	NULL
M.	NULL
,	NULL
T.	NULL
Fujita	NULL
,	NULL
Y.	NULL
Kimura	NULL
,	NULL
M.	NULL
Maruyama	NULL
,	NULL
H.	NULL
Harada	NULL
,	NULL
Y.	NULL
Sudo	NULL
,	NULL
T.	NULL
Miyata	NULL
,	NULL
and	NULL
T.	NULL
Taniguchi	NULL
.	NULL

1988	NULL
.	NULL

Regulated	NULL
expression	NULL
of	NULL
a	NULL
gene	NULL
encoding	NULL
a	NULL
nuclear	NULL
factor	NULL
,	NULL
IRF-1	NULL
,	NULL
that	NULL
specifically	NULL
binds	NULL
to	NULL
IFN-	NULL
gene	NULL
regulatory	NULL
elements	NULL
.	NULL

Cell	NULL
54:903	NULL
.	NULL

13	NULL
.	NULL

Tanaka	NULL
,	NULL
N.	NULL
,	NULL
M.	NULL
Ishihara	NULL
,	NULL
M.	NULL
Kitagawa	NULL
,	NULL
H.	NULL
Harada	NULL
,	NULL
T.	NULL
Kimura	NULL
,	NULL
T.	NULL
Matsuyama	NULL
,	NULL
M.	NULL
S.	NULL
Lamphier	NULL
,	NULL
S.	NULL
Aizawa	NULL
,	NULL
T.	NULL
W.	NULL
Mak	NULL
,	NULL
and	NULL
T.	NULL
Taniguchi	NULL
.	NULL

1994	NULL
.	NULL

Cellular	NULL
commitment	NULL
to	NULL
oncogene-induced	NULL
transformation	NULL
or	NULL
apoptosis	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
transcription	NULL
factor	NULL
IRF-1	NULL
.	NULL

Cell	NULL
77:829	NULL
.	NULL

14	NULL
.	NULL

Tamura	NULL
,	NULL
T.	NULL
,	NULL
M.	NULL
Ishihara	NULL
,	NULL
M.	NULL
S.	NULL
Lamphier	NULL
,	NULL
N.	NULL
Tanaka	NULL
,	NULL
I.	NULL
Oishi	NULL
,	NULL
S.	NULL
Aizawa	NULL
,	NULL
T.	NULL
Matsuyama	NULL
,	NULL
T.	NULL
W.	NULL
Mak	NULL
,	NULL
S.	NULL
Taki	NULL
,	NULL
and	NULL
T.	NULL
Taniguchi	NULL
.	NULL

1995	NULL
.	NULL

An	NULL
IRF-1-dependent	NULL
pathway	NULL
of	NULL
DNA	NULL
damage-induced	NULL
apoptosis	NULL
in	NULL
mitogen-activated	NULL
T	NULL
lymphocytes	NULL
.	NULL

Nature	NULL
376:596	NULL
.	NULL

15	NULL
.	NULL

Kamijo	NULL
,	NULL
R.	NULL
,	NULL
H.	NULL
Harada	NULL
,	NULL
T.	NULL
Matsuyama	NULL
,	NULL
M.	NULL
Bosland	NULL
,	NULL
J.	NULL
Gerecitano	NULL
,	NULL
D.	NULL
Shapiro	NULL
,	NULL
J	NULL
.	NULL

Le	NULL
,	NULL
S.	NULL
I.	NULL
Koh	NULL
,	NULL
T.	NULL
Kimura	NULL
,	NULL
S.	NULL
J	NULL
.	NULL

Green	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1994	NULL
.	NULL

Requirement	NULL
for	NULL
transcription	NULL
factor	NULL
IRF-1	NULL
in	NULL
NO	NULL
synthase	NULL
induction	NULL
in	NULL
macrophages	NULL
.	NULL

Science	NULL
263:1612	NULL
.	NULL

16	NULL
.	NULL

Ogasawara	NULL
,	NULL
K.	NULL
,	NULL
S.	NULL
Hida	NULL
,	NULL
N.	NULL
Azimi	NULL
,	NULL
Y.	NULL
Tagaya	NULL
,	NULL
T.	NULL
Sato	NULL
,	NULL
T.	NULL
Yokochi-Pukuda	NULL
,	NULL
T.	NULL
A.	NULL
Waldmann	NULL
,	NULL
T.	NULL
Taniguchi	NULL
,	NULL
and	NULL
S.	NULL
Taki	NULL
.	NULL

1998	NULL
.	NULL

Requirement	NULL
for	NULL
IRF-1	NULL
in	NULL
the	NULL
microenvironment	NULL
supporting	NULL
development	NULL
of	NULL
natural	NULL
killer	NULL
cells	NULL
.	NULL

Nature	NULL
391:700	NULL
.	NULL

17	NULL
.	NULL

Penninger	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
C.	NULL
Sirard	NULL
,	NULL
H.	NULL
W.	NULL
Mittrucker	NULL
,	NULL
A.	NULL
Chidgey	NULL
,	NULL
I.	NULL
Kozieradzki	NULL
,	NULL
M.	NULL
Nghiem	NULL
,	NULL
A.	NULL
Hakem	NULL
,	NULL
T.	NULL
Kimura	NULL
,	NULL
E.	NULL
Timms	NULL
,	NULL
R.	NULL
Boyd	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
interferon	NULL
regulatory	NULL
transcription	NULL
factor	NULL
IRF-1	NULL
controls	NULL
positive	NULL
and	NULL
negative	NULL
selection	NULL
of	NULL
CD8	NULL
*	NULL
thymocytes	NULL
.	NULL

Immunity	NULL
7:243	NULL
.	NULL

18	NULL
.	NULL

Taki	NULL
,	NULL
S.	NULL
,	NULL
T.	NULL
Sato	NULL
,	NULL
K.	NULL
Ogasawara	NULL
,	NULL
T.	NULL
Fukuda	NULL
,	NULL
M.	NULL
Sato	NULL
,	NULL
S.	NULL
Hida	NULL
,	NULL
G.	NULL
Suzuki	NULL
,	NULL
M.	NULL
Mitsuyama	NULL
,	NULL
E.	NULL
H.	NULL
Shin	NULL
,	NULL
S.	NULL
Kojima	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1997	NULL
.	NULL

Multistage	NULL
regulation	NULL
of	NULL
Th1-type	NULL
immune	NULL
responses	NULL
by	NULL
the	NULL
transcription	NULL
factor	NULL
IRF-1	NULL
.	NULL

Immunity	NULL
6:673	NULL
.	NULL

19	NULL
.	NULL

Lohoff	NULL
,	NULL
M.	NULL
,	NULL
D.	NULL
Ferrick	NULL
,	NULL
H.	NULL
W.	NULL
Mittrucker	NULL
,	NULL
G.	NULL
S.	NULL
Duncan	NULL
,	NULL
S.	NULL
Bischof	NULL
,	NULL
M.	NULL
Rollinghoff	NULL
,	NULL
and	NULL
T.	NULL
W.	NULL
Mak	NULL
.	NULL

1997	NULL
.	NULL

Interferon	NULL
regulatory	NULL
factor-1	NULL
is	NULL
required	NULL
for	NULL
a	NULL
T	NULL
helper	NULL
1	NULL
immune	NULL
response	NULL
in	NULL
vivo	NULL
.	NULL

Immunity	NULL
6:681	NULL
.	NULL

20	NULL
.	NULL

Ma	NULL
,	NULL
X.	NULL
,	NULL
J.	NULL
M.	NULL
Chow	NULL
,	NULL
G.	NULL
Gri	NULL
,	NULL
G.	NULL
Carra	NULL
,	NULL
F.	NULL
Gerosa	NULL
,	NULL
S.	NULL
F.	NULL
Wolf	NULL
,	NULL
R.	NULL
Dzialo	NULL
,	NULL
and	NULL
G.	NULL
Trinchieri	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
interleukin	NULL
12	NULL
p40	NULL
gene	NULL
promoter	NULL
is	NULL
primed	NULL
by	NULL
interferon	NULL
y	NULL
in	NULL
monocytic	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

183:147	NULL
.	NULL

21	NULL
.	NULL

Bach	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
M.	NULL
Aguct	NULL
,	NULL
and	NULL
R.	NULL
D.	NULL
Schreiber	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
IFN-y	NULL
receptor	NULL
:	NULL
a	NULL
paradigm	NULL
for	NULL
cytokine	NULL
receptor	NULL
signaling	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

15:563	NULL
.	NULL

22	NULL
.	NULL

Pine	NULL
,	NULL
R.	NULL
,	NULL
A.	NULL
Canova	NULL
,	NULL
and	NULL
C.	NULL
Schindler	NULL
.	NULL

1994	NULL
.	NULL

Tyrosine	NULL
phosphorylated	NULL
p91	NULL
binds	NULL
to	NULL
a	NULL
single	NULL
element	NULL
in	NULL
the	NULL
ISGF2/IRF-1	NULL
promoter	NULL
to	NULL
mediate	NULL
induction	NULL
by	NULL
IFN-	NULL
@	NULL
and	NULL
IFN-y	NULL
,	NULL
and	NULL
is	NULL
likely	NULL
to	NULL
autoregulate	NULL
the	NULL
p91	NULL
gene	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13:158	NULL
.	NULL

23	NULL
.	NULL

Chen	NULL
,	NULL
M.	NULL
,	NULL
A.	NULL
Cheng	NULL
,	NULL
Y.-Q	NULL
.	NULL

Chen	NULL
,	NULL
A.	NULL
Hymel	NULL
,	NULL
E.	NULL
P.	NULL
Hanson	NULL
,	NULL
L.	NULL
Kimmel	NULL
,	NULL
Y.	NULL
Minami	NULL
,	NULL
T.	NULL
Taniguchi	NULL
,	NULL
P.	NULL
S.	NULL
Changelian	NULL
,	NULL
and	NULL
J.	NULL
J.	NULL
O'Shea	NULL
.	NULL

1997	NULL
.	NULL

The	NULL
amino	NULL
terminus	NULL
of	NULL
JAK3	NULL
is	NULL
necessary	NULL
and	NULL
sufficient	NULL
for	NULL
binding	NULL
to	NULL
the	NULL
common	NULL
-y	NULL
chain	NULL
and	NULL
confers	NULL
the	NULL
ability	NULL
to	NULL
transmit	NULL
interleukin	NULL
2-mediated	NULL
signals	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94:6910	NULL
.	NULL

24	NULL
.	NULL

Ohmori	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
T.	NULL
A.	NULL
Hamilton	NULL
.	NULL

1997	NULL
.	NULL

IL-4-induced	NULL
STAT6	NULL
suppresses	NULL
IFN-y-stimulated	NULL
STAT	NULL
transcription	NULL
in	NULL
mouse	NULL
macrophages	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

159:5474	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL
7262	NULL
25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

Zhou	NULL
,	NULL
Y.	NULL
J.	NULL
,	NULL
E.	NULL
P.	NULL
Hanson	NULL
,	NULL
Y.	NULL
Q.	NULL
Chen	NULL
,	NULL
K.	NULL
Magnuson	NULL
,	NULL
M.	NULL
Chen	NULL
,	NULL
P.	NULL
G.	NULL
Swann	NULL
,	NULL
R.	NULL
L.	NULL
Wange	NULL
,	NULL
P.	NULL
S.	NULL
Changelian	NULL
,	NULL
and	NULL
J.	NULL
J.	NULL
O'Shea	NULL
.	NULL

1997	NULL
.	NULL

Distinct	NULL
tyrosine	NULL
phosphorylation	NULL
sites	NULL
in	NULL
JAK3	NULL
kinase	NULL
domain	NULL
positively	NULL
and	NULL
negatively	NULL
regulate	NULL
its	NULL
enzymatic	NULL
activity	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
94:13850	NULL
.	NULL

Bug	NULL
,	NULL
G.	NULL
,	NULL
M.	NULL
J.	NULL
Aman	NULL
,	NULL
T.	NULL
Tretter	NULL
,	NULL
C.	NULL
Huber	NULL
,	NULL
and	NULL
C.	NULL
Peschel	NULL
.	NULL

1998	NULL
.	NULL

Induction	NULL
of	NULL
macrophage-inflammatory	NULL
protein	NULL
1	NULL
@	NULL
(	NULL
MIP-1	NULL
@	NULL
)	NULL
by	NULL
interferon-	NULL
.	NULL

Exp	NULL
.	NULL

Hematol	NULL
.	NULL

26:117	NULL
.	NULL

Huang	NULL
,	NULL
Y.	NULL
,	NULL
L.	NULL
M.	NULL
Blatt	NULL
,	NULL
and	NULL
M.	NULL
W.	NULL
Taylor	NULL
.	NULL

1995	NULL
.	NULL

Type	NULL
1	NULL
interferon	NULL
as	NULL
an	NULL
anti-inflammatory	NULL
agent	NULL
:	NULL
inhibition	NULL
of	NULL
lipopolysaccharide-induced	NULL
interleukin-1	NULL
and	NULL
induction	NULL
of	NULL
interleukin-1	NULL
receptor	NULL
antagonist	NULL
.	NULL

J.	NULL
Interferon	NULL
Cytokine	NULL
Res	NULL
.	NULL

15:317	NULL
.	NULL

Veals	NULL
,	NULL
S.	NULL
A.	NULL
,	NULL
D.	NULL
S.	NULL
Kessler	NULL
,	NULL
S.	NULL
Josiah	NULL
,	NULL
D.	NULL
G.	NULL
Leonard	NULL
,	NULL
and	NULL
D.	NULL
E.	NULL
Levy	NULL
.	NULL

1991	NULL
.	NULL

Signal	NULL
transduction	NULL
pathway	NULL
activating	NULL
interferon-a-stimulated	NULL
gene	NULL
expression	NULL
.	NULL

Br	NULL
.	NULL

J.	NULL
Haematol	NULL
.	NULL

79	NULL
(	NULL
Suppl	NULL
.	NULL

1	NULL
)	NULL
:9	NULL
.	NULL

Salcedo	NULL
,	NULL
T.	NULL
W.	NULL
,	NULL
L.	NULL
Azzoni	NULL
,	NULL
S.	NULL
F.	NULL
Wolf	NULL
,	NULL
and	NULL
B.	NULL
Perussia	NULL
.	NULL

1993	NULL
.	NULL

Modulation	NULL
of	NULL
perforin	NULL
and	NULL
granzyme	NULL
messenger	NULL
RNA	NULL
expression	NULL
in	NULL
human	NULL
natural	NULL
killer	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

151:2511	NULL
.	NULL

Thierfelder	NULL
,	NULL
W.	NULL
E.	NULL
,	NULL
J.	NULL
M.	NULL
van	NULL
Deursen	NULL
,	NULL
K.	NULL
Yamamoto	NULL
,	NULL
R.	NULL
A.	NULL
Tripp	NULL
,	NULL
S.	NULL
R.	NULL
Sarawar	NULL
,	NULL
R.	NULL
T.	NULL
Carson	NULL
,	NULL
M.	NULL
Y.	NULL
Sangster	NULL
,	NULL
D.	NULL
A.	NULL
Vignali	NULL
,	NULL
P.	NULL
C.	NULL
Doherty	NULL
,	NULL
G.	NULL
C.	NULL
Grosveld	NULL
,	NULL
and	NULL
J.	NULL
N.	NULL
Thie	NULL
.	NULL

1996	NULL
.	NULL

Requirement	NULL
for	NULL
Stat4	NULL
in	NULL
interleukin-12-mediated	NULL
responses	NULL
of	NULL
natural	NULL
killer	NULL
and	NULL
T	NULL
cells	NULL
.	NULL

Nature	NULL
382:171	NULL
.	NULL

Kaplan	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
Y.	NULL
L.	NULL
Sun	NULL
,	NULL
T.	NULL
Hoey	NULL
,	NULL
and	NULL
M.	NULL
J.	NULL
Grusby	NULL
.	NULL

1996	NULL
.	NULL

Impaired	NULL
IL-12	NULL
responses	NULL
and	NULL
enhanced	NULL
development	NULL
of	NULL
Th2	NULL
cells	NULL
in	NULL
Stat4-deficient	NULL
mice	NULL
.	NULL

Nature	NULL
382:174	NULL
.	NULL

Seder	NULL
,	NULL
R.	NULL
A.	NULL
,	NULL
R.	NULL
Gazzinelli	NULL
,	NULL
A.	NULL
Sher	NULL
,	NULL
and	NULL
W.	NULL
E.	NULL
Paul	NULL
.	NULL

1993	NULL
.	NULL

Interleukin	NULL
12	NULL
acts	NULL
directly	NULL
on	NULL
CD4*	NULL
T	NULL
cells	NULL
to	NULL
enhance	NULL
priming	NULL
for	NULL
interferon	NULL
y	NULL
production	NULL
and	NULL
diminishes	NULL
interleukin	NULL
4	NULL
inhibition	NULL
of	NULL
such	NULL
priming	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:10188	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

INDUCTION	NULL
OF	NULL
IRF-1	NULL
BY	NULL
IL-12	NULL
AND	NULL
IL-2	NULL
,	NULL
BUT	NULL
NOT	NULL
BY	NULL
IL-4	NULL
Brinkmann	NULL
,	NULL
V.	NULL
,	NULL
T.	NULL
Geiger	NULL
,	NULL
S.	NULL
Alkan	NULL
,	NULL
and	NULL
C.	NULL
H.	NULL
Heusser	NULL
.	NULL

1993	NULL
.	NULL

Interferon	NULL
a	NULL
increases	NULL
the	NULL
frequency	NULL
of	NULL
interferon	NULL
y-producing	NULL
human	NULL
CD4*	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178:1655	NULL
.	NULL

Rogge	NULL
,	NULL
L.	NULL
,	NULL
L.	NULL
Barberis-Maino	NULL
,	NULL
M.	NULL
Biffi	NULL
,	NULL
N.	NULL
Passini	NULL
,	NULL
D.	NULL
H.	NULL
Presky	NULL
,	NULL
U.	NULL
Gubler	NULL
,	NULL
and	NULL
F.	NULL
Sinigaglia	NULL
.	NULL

1997	NULL
.	NULL

Selective	NULL
expression	NULL
of	NULL
an	NULL
interleukin-12	NULL
receptor	NULL
component	NULL
by	NULL
human	NULL
T	NULL
helper	NULL
1	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

185:825	NULL
.	NULL

Schrum	NULL
,	NULL
S.	NULL
,	NULL
P.	NULL
Probst	NULL
,	NULL
B.	NULL
Fleischer	NULL
,	NULL
and	NULL
P.	NULL
F.	NULL
Zipfel	NULL
.	NULL

1996	NULL
.	NULL

Synthesis	NULL
of	NULL
the	NULL
CC-chemokines	NULL
MIP-1	NULL
@	NULL
,	NULL
MIP-1	NULL
$	NULL
,	NULL
and	NULL
RANTES	NULL
is	NULL
associated	NULL
with	NULL
a	NULL
type	NULL
1	NULL
immune	NULL
response	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

157:3598	NULL
.	NULL

Aman	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
U.	NULL
Keller	NULL
,	NULL
G.	NULL
Derigs	NULL
,	NULL
M.	NULL
Mohamadzadeh	NULL
,	NULL
C.	NULL
Huber	NULL
,	NULL
and	NULL
C.	NULL
Peschel	NULL
.	NULL

1994	NULL
.	NULL

Regulation	NULL
of	NULL
cytokine	NULL
expression	NULL
by	NULL
interferon-a	NULL
in	NULL
human	NULL
bone	NULL
marrow	NULL
stromal	NULL
cells	NULL
:	NULL
inhibition	NULL
of	NULL
hematopoietic	NULL
growth	NULL
factors	NULL
and	NULL
induction	NULL
of	NULL
interleukin-1	NULL
receptor	NULL
antagonist	NULL
.	NULL

Blood	NULL
84:4142	NULL
.	NULL

Siveke	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
and	NULL
A.	NULL
Hamann	NULL
.	NULL

1998	NULL
.	NULL

T	NULL
helper	NULL
1	NULL
and	NULL
T	NULL
helper	NULL
2	NULL
cells	NULL
respond	NULL
differentially	NULL
to	NULL
chemokines	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

160:550	NULL
.	NULL

Yamamoto	NULL
,	NULL
K.	NULL
,	NULL
F.	NULL
W.	NULL
Quelle	NULL
,	NULL
W.	NULL
E.	NULL
Thierfelder	NULL
,	NULL
B.	NULL
L.	NULL
Kreider	NULL
,	NULL
D.	NULL
J.	NULL
Gilbert	NULL
,	NULL
N.	NULL
A.	NULL
Jenkins	NULL
,	NULL
N.	NULL
G.	NULL
Copeland	NULL
,	NULL
O.	NULL
Silvennoinen	NULL
,	NULL
and	NULL
J.	NULL
N.	NULL
Ihle	NULL
.	NULL

1994	NULL
.	NULL

Statd	NULL
,	NULL
a	NULL
novel	NULL
y	NULL
interferon	NULL
activation	NULL
site-binding	NULL
protein	NULL
expressed	NULL
in	NULL
early	NULL
myeloid	NULL
differentiation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:4342	NULL
.	NULL

Nelson	NULL
,	NULL
N.	NULL
,	NULL
Y.	NULL
Kanno	NULL
,	NULL
C.	NULL
Hong	NULL
,	NULL
C.	NULL
Contursi	NULL
,	NULL
T.	NULL
Fujita	NULL
,	NULL
B.	NULL
J.	NULL
Fowlkes	NULL
,	NULL
E.	NULL
O'Connell	NULL
,	NULL
J.	NULL
Hu-Li	NULL
,	NULL
W.	NULL
E.	NULL
Paul	NULL
,	NULL
D.	NULL
Jankovic	NULL
,	NULL
A.	NULL
F.	NULL
Sher	NULL
,	NULL
J.	NULL
E.	NULL
Coligan	NULL
,	NULL
A.	NULL
Thornton	NULL
,	NULL
E.	NULL
Appella	NULL
,	NULL
Y.	NULL
Yang	NULL
,	NULL
and	NULL
K.	NULL
Ozato	NULL
.	NULL

1996	NULL
.	NULL

Expression	NULL
of	NULL
IFN	NULL
regulatory	NULL
factor	NULL
family	NULL
proteins	NULL
in	NULL
lymphocytes	NULL
:	NULL
induction	NULL
of	NULL
STAT-1	NULL
and	NULL
IFN	NULL
consensus	NULL
sequence	NULL
binding	NULL
protein	NULL
expression	NULL
by	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

156:3711	NULL
.	NULL

6107	NULL
'0t	NULL
4epy	NULL
uo	NULL
1san8	NULL
4q	NULL
[	NULL
810	NULL
fountwrut	NULL
[	NULL
'mmmy	NULL
;	NULL
/	NULL
:	NULL
dyy	NULL
wor	NULL

